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Fasciclin I is a cell surface glycoprotein thought to be involved in growth cone 
guidance in the embryonic insect nervous system. It is expressed on the cell surfaces of all 
peripheral nervous system (PNS) axons, a subset of central nervous system (CNS) axons 
and on some nonneuronal cells. Fly embryos bearing mutations eliminating expression of 
both fasciclin I and the Abelson tyrosine kinase exhibit a severe phenotype in which many 
axon pathways fail to form. Fasciclin I mediates homophilic adhesion in transfected tissue 
culture cells, suggesting that it may affect growth cone guidance through homophilic 
interactions. To facilitate structure-function studies of fasciclin I, we have generated 
mammalian (CHO) cell lines expressing fasciclin I at a high level. The expressed fasciclin I 
protein was released from the cell surface in a soluble form by phospholipase C treatment. 
Milligram quantities of soluble expressed fasciclin I were purified on an immunoaffinity 
column. Large single crystals were obtained that diffracted to -5 A resolution which is 
insufficient for a structure determination to atomic resolution by x-ray crystallography. In 
an effort to produce a form of fasciclin I more amenable to crystallization, we also 
generated CHO and Drosophila cell (S2) lines that produce a truncated form of fasciclin I. 
The soluble fasciclin I expressed in S2 cells contains significantly less carbohydrate (-15 
kDa) as compared to the molecules expressed in CHO cells. Therefore, S2-derived 
fasciclin I may be more suitable for crystallization. Biochemical characterization of the 
expressed fasciclin I indicates that fasciclin I exists as a monomer in solution, an 
observation consistent with homophilic interaction properties only if the interaction is of 
low affinity. Electron micrographs of fasciclin I suggest that it has a compact rectangular 
shape with no obvious flexible linker regions, in contrast to what has been seen in electron 
microscopic studies of other adhesion molecules. Circular dichroism analysis suggests that 
fasciclin I contains significant amounts of a-helical structure, which together with the 
electron microscopic results, suggests that its structure is substantially different from the 13-
Vll 
sheet structures predicted for adhesion molecules that are members of the immunoglobulin 
superfamily and/or contain fibronectin III repeats. Future structural and functional studies 
of fasciclin I will ultimately increase our understanding of neuronal cell surface recognition 
and axon guidance. 
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The nervous system regulates all aspects of bodily function. It is staggering in its 
complexity. In humans, there are about 1012 nerve cells in the brain, each with extensive 
wiring for an appropriate communication. How do neurons follow specific pathways and 
recognize their targets during development? This chapter first discusses a highly 
specialized and versatile navigational machine, the growth cone, that makes the pathway 
decisions, and the labeled pathway hypothesis proposed for growth cone steering. Section 
II focuses on discussing current knowledge concerning the properties and roles of cell 
adhesion molecules in vertebrates and in invertebrates underlying axonal migration and 
guidance. Finally, the primary structure and functions of fasciclin I, a cell surface molecule 
thought to be involved in neural development will be discussed. 
3 
I. Growth Cone Guidance and Labeled Pathway Hypothesis 
How neuronal growth cones follow specific pathways and recognize their targets is a 
central issue in developmental neurobiology. In 1880, Ramon y Cajal already observed 
and named the growth cone as the structure at the end of embryonic axons. Although he 
had only fixed histological slides, Cajal proposed the growth cone in these static images as 
a "sort of club or battering ram, endowed with exquisite chemical sensitivity, with rapid 
ameboid movements, and with certain impulsive force, thanks to which it is able to proceed 
forward and overcome obstacles met in its way, forcing cellular interstices until it arrives at 
its final destination." He further stated "what mysterious forces precede the appearance of 
these prolongations, promote their growth and ramification, and finally establish the 
protoplasmic kisses, the intercellular articulations that appear to constitute the final ecstasy 
of an epic love story." Harrison confirmed Cajal's hypothesis that the outgrowth of axonal 
processes was not random by observing the extension of growth cones from living frog 
spinal cord explants in tissue culture (1910). He found that growth cones extended along 
stereotyped pathways to find and recognize their correct targets. 
Advanced technologies developed in recent years, including the use of fluorescent, 
nontoxic lipophilic dyes to label growing axons in either cell cultures or living embryonic 
preparations, in combination with the use of confocal fluorescence and video-enhanced 
microscopy, make possible the observation of axonal navigation with remarkable clarity. 
From observations of both vertebrate and invertebrate systems, it appears that the growth 
cone is a highly motile structure composed of a broad, flat expanse of neurite, like a palm 
of the hand, with many long fingerlike filopodia and a ruffling membrane called a 
lamellipodium (Fig. 1). As axons grow, their growth cones continually extend and retract 
their filopodial and lamellipodial processes, in apparent exploration of the 
microenvironment, presumably for making navigational decisions among "environmental 
4 




Fig. 1. A schematic view of the growth cone at the end of the axon. Microtubules in the 
axon are closely packed and axially aligned, but the many fewer and less organized in the 
growth cone. An actin network is prominent at the leading edge of the growth cone, and 
bundles of actin filaments fill the filopodia. The central region of the growth cone is rich in 
mitochondria and vesicles. The arrows indicate that while the leading edge of the growth 
cone is advancing in one direction, filopodia and lamellipodia are swept back over the 
surface of the growth cone in the opposite direction. 
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What are environmental cues and how do they work? To address these questions at 
the level of individual cellular interactions at a molecular level, the relatively simple nervous 
system of insect embryos has been used. This is because the mammalian nervous system 
is composed of hundreds of billions of nerve cells, each with extensive wiring. In 
contrast, at early stages of grasshopper neuronal development, there are less than 100 
neurons in each hemisegment that extend single unbranched axons. Thus, insect embryos 
provide a useful system to identify and analyze pathway recognition by individual neurons, 
and to examine the molecular mechanisms involved in neuronal recognition (Goodman et 
al., 1984; Bastiani et al., 1985). Each developing segmental ganglion in the insect central 
nevous system (eNS) arises from the neuroepithelium and consists of a ventral layer of 
neuronal precursor cells, a middle layer of cell bodies of their neuronal progeny, and a 
dorsal layer of neuronal processes. As each neuron differentiates, it extends a growth cone 
dorsally into the region called neuropil in which all of the axonal and dendritic processes 
intertwine and interconnect. The neuropil initially develops as an orthogonal scaffold of 
axon bundles or fascicles organized into commissures that connect the two sides of a single 
segment, longitudinal tracts that connect neighboring segments, and nerves that connect the 
segmental ganglion to the periphery. 
Initial insights into how growth cones work have corne from a series of laser ablation 
experiments in grasshopper embryos (Raper et al., 1983a, 1984; Bastiani et al.,1984, 
1986; du Lac et al., 1986; Doe et al., 1986), which showed that an identified growth cone, 
crossing over many bundles, could display a selective affinity for the surface of a specific 
fascicle ofaxons among neighboring fascicles (a process called selective fasciculation). In 
the grasshopper embryo, the long filopodial extensions from individual growth cones can 
sometimes contact as many as 25 different fascicles (containing in total about 100 different 
axons), yet these growth cones always choose to extend along one particular bundle of 
axons (Fig. 2). For example, the G growth cone extends across the embryo all the way on 
6 
a particular commissural bundle, and then invariably turns anteriorly on a longitudinal 
bundle containing the axons of the A and P neurons. If the P axons are eliminated by laser 
ablation, the G growth cone stalls at the end of the commissure. In contrast, if the A axons 
are ablated, the G growth cone behaves normally. Similar results were also obtained in a 
venebrate CNS, the developing fish spinal cord (Kuwada, 1986). These observations 
strongly suggest that axon fascicles express different molecular labels that can be read by 
growing axons. This is called the labeled pathways hypothesis (Raper et aI., 1983c, 
1984), which predicts that each axon pathway is differentially labeled by surface 
recognition molecules that allow growth cones to identify it. 
Neuronal growth cones must respond to cues directing them to follow the appropriate 
pathways and then stop at the correct destination. Cell surface molecules are likely to be of 
primary importance in mediating the recognition of specific extrinsic pathway and target 
cues. In recent years, an impressive amount has been learned about cell surface and 
extracellular matrix molecules that may serve as "adhesion molecules" for cell and substrate 
adhesion as well as axon fasciculation (Jessel et al., 1988). M~ny of these molecules are 
related, and can be grouped into families; this will be discussed in the next section. 
Although a simple model of growth cone navigation based on differential adhesion of 
growth cones to the substratum has been proposed for pathfinding, other possible 
mechanisms such as inhibitory factors cannot be excluded (Dodd and Jessell, 1988, Fig. 
3). In fact, a large amount of data has emerged suggesting that specific inhibitors of axon 
growth also exist. The best characterized growth cone-collapsing activity was identified as 
a component of CNS myelin (Schwab and Caroni, 1988). As growth cones approach 
fragments of myelin or the surfaces of oligodendrocytes, the contact of one or a few 
filopodia with myelin results in a collapse of growth cone structure (loss of most filopodia 
and lamellipodia), as well as a profound and sometimes long-lasting loss of motility 
(Bandtlow et aI., 1990). Collapse of a retinal growth cone upon contact with a particular 
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sympathetic neurite was also observed (Kapfhammer and Raper, 1987; Raper anc~ 
Kapfhammer, 1990). Such inhibitory effects limit axon regeneration in adults as well as 
serve as a guidance function in normal development. 
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Fig. 2. Schematic diagram of selective fasciculation in the grasshopper embryo. A portion 
of the growth cones of the identified neurons in one hemisegment is labeled with their 
distinctive name. The axons form an orthogonal array of bundles by selective 
fasciculation, displaying the divergent and cell-specific choices. A given neuron, such as 
aCC, makes multiple choices as it grows, passing by some bundles (such as those formed 
by pCC, MPI and dMP2) and joining up and growing along other bundles (such as those 
formed by VI, U2, RPl, and RP2) (from Goodman et al., 1984). 
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Fig. 3. Growth cones recognize specific guidance cues in their local environment. (A) Cell 
surface or ECM molecules that inhibit growth cones may contribute to their choice of 
substrate pathways and to selective fasciculations. (B) Adhesion molecules expressed on 
developing growth cones and axons may promote selective fasciculation and growth cone 
extension on preexisting axon tracts. (C) Growth cones may respond to gradients of 
diffusible molecules that are secreted by discrete cellular targets, thus orienting axonal 
projections by a chemotropic mechanism. (0) Intermediate cellular targets may mediate 
abrupt alterations in axonal pathways (from Dodd and Jessell, 1988). 
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In addition to protein-protein interactions, complex oligosaccharides can also mediate 
targeting interactions in the nervous system. Proteoglycans, for example, can interact with 
most of the extracellular matrix attachment proteins and at least two immunoglobulin 
superfamily adhesion molecules (N-CAM and myelin-associated glycoproteins). It is 
suggested that at least some proteoglycans may act as barriers to exert inhibitory influences 
on neural cell migration and axon growth (Hynes and Lander, 1992). It is also clear that 
N-CAM possesses a unique oligosaccharide, poly sialic acid, that is predIcted to extend a 
considerable distance beyond the membrane and may influence fasciculation and nerve-
muscle interaction (Rutishauser et al., 1988). 
The classes of molecules discussed above seem likely to provide many of the cues 
that are present on complex pathways along which neurons and growth cones travel. Some 
of the molecules are observed to be physically associated with cytoskeleton components in 
actively motile growth cones, suggesting that some receptors which have direct links to the 
cytoskeleton can alter growth cone motility (Sabry et al., 1991; Tanaka and Kirschner et 
al., 1991). There is also strong evidence that environmental signals may alter growth cone 
motility via second messengers, especially calcium whose concentration influences protein 
phosphorylation and which is required by many actin-binding proteins. Extensive studies 
in the large growth cones of cultured invertebrate neurites (Helisoma, a snail) have been 
done, using the fluorescent calcium sensitive intracellular dye fura-2 and whole-cell patch 
clamping to measure membrane potential (Kater and Mills, 1991). It appears that an 
optimum range of free intracellular calcium is necessary for growth cone extension in these 
experiments. 
The growth cone is clearly a highly specialized and versatile navigational machine. In 
grasshopper embryo limb buds, O'Connor et al. (1990) observed that the growth cones of 
Ti 1 neurons follow a highly stereotyped pathway (Fig. 4) with different kinds of migration 
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and steering events. Typically, the growth cone advances by extending veils between 
filopodia on a relatively homogeneous substrate, as is commonly observed on uniform 
substrate in vitro. At some choice points, for example, when growth cones confront an 
orthogonal border between substrates of dissimilar affinity, axon growth proceeds by 
extension of multiple lamellipodia, consolidation of one or a few lamellipodia into the 
preferred nascent axon, and subsequently retraction of inappropriate filopodia and 
lamellipodial processes. In contrast, a single filopodial contact with a very high-affinity 
substrate, such as a "guidepost cell," can rapidly expand in diameter, filling in with 
axoplasm and abruptly reorient the entire growth cone. Although many molecules that may 
mediate neural adhesion and recognition have been isolated, the molecular mechanisms that 
underlie different kinds of growth cone responses remain to be identified. For instance, 
how are a sufficient number and diversity of molecules expressed at the tip of a thin and 
elongated structure, what signaling pathways conveyed the external messages into the cells, 
and how do filopodial contacts withstand the powerful contractile forces? Only when this 







Fig. 4. Growth cones use many cues along their pathways. In grasshopper embryo limb 
buds, the sibling Ti 1 pioneers are the first neurons to initiate axonogenesis. The pioneer 
gorwth cones migrate from the limb tip to the CNS along a highly stereotyped pathway that 
involves a series of well-defined alterations in direction (a-f) comprising discrete steering 
events (from Caudy and Bentley, 1986; O'Connor et aI., 1990). The initial path of 50 Ilm, 
illustrated as segment a on the right, is reoriented in a proximal-ventral direction as contact 
is made with the first guidepost cell, neuron Fe 1. This forms segment b of the path. At 
this point, the growth cones orient toward the m 1 and m2 cells, forming the c segment. 
The d segment is formed by a contact with the second guidepost cell, Trl. From this point, 
the growth cones tum sharply to follow the segment boundary in the epithelium, forming 
part e of the pathway. The f segment is formed by a distinct reorientation towards the next 
guidepost cells, the ex 1 cells. Leaving these cells the Ti 1 growth cones follow a direct line 
into the CNS along the p cells. . 
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II. Cell Adhesion Molecules 
A. Families of Cell Adhesion Receptors in the Neuronal Processes 
In recent years there have been major advances in identifying numerous cell surface 
molecules in vertebrates which mediate cell-cell or cell-substrate adhesion for the 
associations of neural cells (Dodd and Jessell, 1988; Lander, 1989). There are three major 
classes whose members appear in the different processes performing similar roles (Fig. 5); 
laminins and integrins (Hynes, 1992), cadherins (Takeichi, 1988, 1990, 1991), and the 
immunoglobulin superfamily (Jessell, 1988; Gromet, 1991). Another class of adhesion 
receptors, selectins (Bevilacqua et al., 1991; Lasky and Rosen, 1991), are known to be 
expressed on the surface of various blood cells and/or endothelial cells, and thus will not be 
included in this discussion. 
Neurons recognize and adhere to molecules in the extracellular matrix via receptors on 
the surfaces of growth cones and axons, particularly in cell migration during gastrulation, 
and neural crest migration. One large group of receptors for these matrix proteins is the 
integrin family. The integrins are transmembrane a~ heterodimers. There are currently 
about 20 known integrin heterodimers, made up of various pairings of 8 ~ subunits and 13 
a subunits, yielding heterogeneity in binding specificity (reviewed by Hynes, 1987, 1992; 
Hemler, 1990; Reichardt et al., 1991). Many integrins appear to recognize the Arg-Gly-
Asp (RGD) peptide in the context of other sequences of the extracellular matrix (ECM) 
ligand to which they bind. Each integrin heterodimer has a distinct ligand specificity. A 
large number of adhesive extracellular matrix glycoproteins, such as fibronectins, laminins, 
tenascin, and thrombospondin, are known to be ligands ofintegrins (Lander, 1989). Two 
of these, laminin and fibronectin, which are major components of peripheral neural and 
non-neural extracellular matrices, promote neurite outgrowth by several types of neuron 
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Cadherins Ig Superfamily 
(N -CAM et al) 
Integrins 
Fig. 5. Major families of cell adhesion receptors in neuronal processes. Cadherins are 
calcium-dependent homophilic cell-cell adhesion molecules. Immunoglobulin superfamily 
adhesion receptors contain immunoglobulin domains (half circles) and, frequently, 
fibronectin type III repeats (cross-hatched boxes). These cell-cell adhesion receptors are 
calcium-independent and participate in heterophilic and possibly also homophilic 
interactions. Integrins are heterodimeric receptors, some for extracellular matrix proteins 
and some for immunoglobulin superfamily counter receptors, and therefore can be involved 
in both cell-matrix and cell-cell adhesion. Most receptors are transmembrane proteins, and 
a few are PI-linked. Binding domains are indicated by the darkest colorings (from Hynes 
and Lander, 1992). 
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(Thiery et al., 1989). Antibodies to fibronectin block mesodermal migration in amphibians 
(Boucaut et al., 1984a) and birds (Harrisson, 1989). Similarly, gastrulation can be blocked 
either by RGD tripeptide (Boucaut et aI., 1984b), or by antibodies against integrin subunits 
(Darribere et al., 1988, 1990). In addition, antibodies directed against a laminin/heparan 
sulfate proteoglycan complex also perturb cranial neural crest cell migration in vivo 
(Bronner-Fraser and Lallier, 1988). These observations provide evidence that ECM 
components promote neural crest migration in vivo, and that the appropriate expression of 
integrins and ECM molecules by crest cells is important for this migration. 
When visualized by the electron microscope, integrins appear to be rod-shaped 
molecules extending about 20 nm from the membrane, with globular domains at their 
extracellular termini that include both <X and p subunits (Nermut et al., 1988). This globular 
domain binds the ECM ligand, and the ligand-binding function depends on divalent cations 
(calcium, magnesium and manganesium) (Gailit and Ruoslahti, 1988). Each subunit also 
has a transmembrane and a cytoplasmic domain. Upon binding of ligand, integrins appear 
to transduce signals across the membrane, possibly by regulating second messenger levels 
as well as by direct interactions with cytoskeletal proteins. Among the cytoskeletal proteins 
thought to interact with the cytoplasmic domain of the integrins are talin, vinculin and a-
actinin, each of which is found in neuronal growth cones (reviewed in Burridge et al., 
1988). 
Cadherins are encoded by a functionally related gene family and at least a dozen 
different cadherins are known that all share elements of sequence and structural homology 
(Takeichi, 1988, 1990, 1991). The various types of cadherin (E-type, P-type. and C-
cadherin) cause aggregation in the presence of calcium when expressed on transfected L 
cells (Nagafuchi et aI., 1987; Nose et aI., 1988; Takeichi, 1988, 1990), and moreover, 
cells expressing different types of cadherins appear to be able to segregate from each other 
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to fonn separate aggregates. These results suggest that cadherins mediate calcium-
dependent cell-cell adhesion in a homophilic manner and may function in the segregation of 
different cell types. Analyses of the predicted primary structures reveal that cadherins are 
integra) membrane g)ycoproteins composed of four homologous domains of about 100 
amino acids each in the extracellular domain and a highly conserved cytoplasmic domain 
(Takeichi, 1990). The detenninants for binding specificity have been mapped to the most 
distal repeat using deletion mutants, domain swaps between E- and P-cadherins, and point 
mutants (Nose et al., 1990). Furthennore, truncation of E-cadherin's cytoplasmic domain 
resulted in a loss of cell adhesion, indicating that the conserved cytoplasmic region of 
cadherins may interact with cytoskeletal components (Nagafuchi and Takeichi, 1988). This 
agrees with the observation that E-cadherins colocalize with actin filaments (Boller et al., 
1985; Hirano et al., 1987; Ozawa et al., 1990). Precisely how cadherins are controlled by 
cytoskeletal elements is still unknown. However, two to three molecules are found to 
associate with E-cadherins (Nagafuchi and Takeichi, 1989; Ozawa et al., 1989; McCrea 
and Gumbiner, 1991), which may be links to the cytoskeleton, and/or regulate E-cadherin 
function. These molecules, therefore, may fonn a structural and functional network 
essential for cad herin-mediated cell adhesion. It is possible that interactions between 
individual cadherin molecules are too weak to connect cells, since there is no observation of 
any dimer or oligomer fonnation in the extracellular domain of cadherin (Takeichi, 1990). 
Thus, aggregation of cadherins laterally at cell-cell contact site may be necessary to allow 
an adhesion event to occur. This might be achieved from support by cytoskeleton to 
increase these lateral interactions of cadherins. Alternatively, cytoskeleton might anchor 
these molecules to the cell-cell contact sites. It is interesting to note that T-cadherin, a 
member of the family, apparently has no cytoplasmic domain (Ranscht and Bronner-
Fraser, 1991). Instead, it is linked to the membrane via a glycosyl-phosphatidylinositol 
(PI) anchor. Two fonns of T-cadherin have been detected and the protein has been found 
















Fig. 6. Schematic diagram of neural molecules that are members of the immunoglobulin 
superfamily. Many of these have been indicated to function as cell surface adhesion 
molecules. The immunoglobulin fold domains are indicated by the half circles, and 
fibronectin type III repeats are indicated by cross-hatched boxes. Thy-I, T AG-l, variant 
forms of fasciclin II, contactin and N-CAM are attached to the plasma membrane by a 
phosphatidylinositollinkage as indicated by arrows. 
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The third group is comprised of members of the immunoglobulin superfamily 
(Williams, 1987). Each immunoglobulin-like domain consists of approximately 100 amino 
acids, with the two most highly conserved regions surrounding a pair of cysteines 
separated by 50-60 residues. Immunoglobulin superfamily proteins are by far the most 
populous and functionally diverse family of molecules present on the cell surface of 
lymphocytes as well as neural cells (Fig. 6). Many of these molecules, like N-CAM and 
L 1, are thought to be homophilic and have dramatic effects in assays of cell aggregation 
and neurite outgrowth. The best evidence for homophilic binding is that transfection of N-
CAM cDNA into fibroblast L-cells induces N-CAM dependent cell adhesion (Edelman et 
al., 1987); transfected L-cells expressing N-CAM aggregated with each other or bound 
membrane vesicles form chick brain. Both types of binding can be blocked by anti-N-
CAM antibodies. Mapping of the binding specificity determinants of N-CAM show them 
to be in the two most distal immunoglobulin repeats (Frelinger and Rutishauser, 1986; Cole 
et al., 1986; Cunningham et aI., 1987; Reyes et al., 1990). Unlike the cadherin family, 
members of immunoglobulin superfamily do not have a conserved cytoplasmic domain as 
depicted in Fig. 6. N-CAM, for instance, has three different isoforms different in the 
carboxyl terminal (Rutishauser, 1986) that are derived from alternative mRNA splicing; 
two are transmembrane proteins (180 kDa and 140 kDa), and another (120 kDa) is attached 
to the membrane via a phosphoinositol (PI) anchor. The polypeptides are expressed at 
different times and places during development; for instance, the largest N-CAM (180 kDa) 
first appears after neurulation and only on neural tissue, while the PI-linked form is 
expressed in significant amounts only later at the time of glial maturation (Cunningham et 
aI., 1987). The functions of different isoforms are poorly understood. Probably the 
different cytoplasmic domains interact with different subsets of cytoskeletal components. 
The largest form of N-CAM has been shown to be unable to freely diffuse in the membrane 
and colocalize with myosin heavy chain in the skeletal muscle at early stages of myotube 
maturation (Figarella-Branger et al., 1992). Moreover, Ng-CAM, Ll and Nr-CAM have a 
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highly conserved cytoplasmic domain that may serve this function . Alternatively, they 
might affect conical events involving second messengers; for example, changes in protein 
kinase C levels can affect responses of cells to CAMs (Bixby and Ihabvala, 1990). 
Moreover, recent studies on N-CAM and N-cadherin demonstrated that they might alter cell 
phenotype involving activation of intracellular second messenger pathways (Doheny et aI., 
1991). 
The structure of immunoglobulin domains in an antilxxly (Arnzel and Poljak, 1979) is 
available at an atomic resolution. In addition, the three-dimensional structures of several 
other members of the immunoglobulin superfamily have been determined, including the 
human major histocompatibility complex protein, HLA-A2 (Bjorkman et al., 1987), C04 
(Wang et al., 1990; Ryu et aI. , 1990), C02 (Driscoll et al., 1991) and C08 (Leathy et aI., 
1992). The immunoglobulin fold is best described as two antiparallel ~ sheets packed 
tightly against each other. A common feature shared by immunoglobulin domains is that an 
immunoglobulin domain pairs with another immunoglobulin domain using the same face at 
almost right angles. Hence, domain-domain interactions analogous to the paired 
associations of immunoglobulin C domains may provide the structural basis for the 
homophilic binding of immunoglobulin superfamily molecules (Williams, 1987; Williams, 
1988). In addition to the homophilic interaction, there is also clear evidence that N -CAM 
binds to heparan sulfate proteoglycans (Cole et al., 1986; Reyes et al., 1990). Thus, some 
immunoglobulin superfamily domains may mediate homotypic adhesion between like cells, 
whereas others could mediate heterotypic adhesion between two different cell types. 
As more structure/function data on these adhesion molecules is generated, it has 
become clear that many adhesion molecules have a specific binding domain at the distal end 
of an extended extracellular region. Another interesting biochemical parallel between these 
three classes of integral membrane proteins, especially cadherins and integrins, is that their 
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cytoplasmic extensions appear to interact with the cytoskeleton. This suggests that the 
cytoskeleton may playa primary role in supporting and informing cells of their external 
contacts. The functions of the extracellular parts of these proteins membrane-proximal to 
their binding domains are unknown, but their conservation argues that they may playa role 
in modulation of cell-cell adhesion or in conformational changes and signal transduction 
events. 
B. Adhesion Molecules in Drosophila 
Although numerous adhesion molecules have been identified as described above, little 
was known about how these molecules were involved in growth cone guidance, due in part 
to the complexity of the neuronal network in vertebrates. Invertebrates have somewhat 
simpler nervous systems. Furthermore, genetic analysis in the fruitfly and nematode may 
facilitate an understanding of the role of adhesion molecules during the development. In 
the past four years, an increasing number of genes encoding adhesion molecules in 
invertebrates have been cloned and characterized. Several approaches have been used to 
identify adhesion molecules in Drosophila: screening monoclonal antibodies against 
dissected grasshopper and Drosophila embryos to search for putative recognition 
molecules; identification of a gene based on a mutant phenotype; and the use of polymerase 
chain reaction (peR) or low stringency hybridization to clone genes by homology to their 
vertebrate counterparts. The molecules thus far identified are summarized in Table 1 
(reviewed by Hortsch and Goodman, 1991). The common picture emerging from these 
recent studies is that many of the adhesion molecules found in Drosophila have 
considerable structural and sequence homology to the counterparts of vertebrates, 
indicating that these molecules probably evolved from the same ancestral proteins. Here, 
we will focus on the adhesion molecules of the fruitfly, Drosophila melanogaster, and 
compare with their vertebrate counterparts. 
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Table 1. Drosophila gene families containing cell and substrate adhesion molecules. 
Name of molecule N umber of repeat Chromosomal Mutants References 
units position exist? 
lntegrin family 
molecules 
PS2 cx2 chain (inflated)8 15Al-5 yes Bogaert et aI . 1987 
PS3 131 chain [lethal (I )myosperoid] 701-5 yes MacKrell et al. 1988 
Laminin molecules EGF repeats 
Laminin A subunit (>16) 65AIO-11 yes Montell & Goodman 
1988 
Montell & Goodman 
Laminin Bl 13 280 1988. 1989; 
subunit Chi & Hui 1989 
Laminin B2 12 67C Montell & Goodman 
subunit 1988 
Immunoglobuhn (Ig) Ig Fn repeats 
domain molecules domains 
Neuroglian 6 5 7F yes Bieber et aI. 1989 
Fasciclin II 5 2 4BI-2 yes Grenningloh et aI. 
1990. 1991 
Fasciclin III 3 0 36El yes Snow et aI . 1989 
Amalgam 3 0 84BI-2 yes Seeger et al. 1988 
Cadherin-like molecules Cadherin domains 
Fat 34 240 yes Mahoney et aI. 1991 
Oachsous (>17) 210 yes H. Clark et al. 
(unpublished) 
Other cell adhesion molecules 
Fasciclin I 4 890 yes Zinn et aI. 1988; 
Elkins et aI. 1990b 
8 Boldface names designate molecules that have either been directly shown to be adhesion molecules (e.g. in 
the S2 cell aggregation assay; Snow et aI .• 1989) or alternatively. are the Drosophila homologues of well 
known vertebrate adhesion molecules. 
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By screening a panel of monoclonal antibodies (mAbs) against dissected grasshopper 
and Drosophila embryos in an attempt to identify putative recognition molecules, four 
candidates were initially characterized: fasciclin I, fasciclin II, fasciclin III, and neuroglian 
(Bastiani et aI., 1987; Patel et aI., 1987; Harrelson and Goodman, 1988; Snow et aI., 
1989; Bieber et aI., 1989; Grenningloh et aI., 1990). These molecules are expressed on 
different overlapping subsets of fasciculating axons and growth cones during neuronal 
development in insects. cDNA clones for these proteins have been isolated and sequenced 
(Zinn et aI., 1988; Grenningloh et aI., 1991; Snow et aI., 1989; Bieber et aI., 1989). 
Fasciclin II, fasciclin III and neuroglian are shown to be members of the immunoglobulin 
gene superfamily. Fasciclin II displays a strong structural and sequence homology to N-
CAM (Harrelson and Goodman, 1988; Grenningloh et aI., 1991), whereas neuroglian is 
most closely related to Ll (Bieber et aI., 1989). Fasciclin III has more divergent 
immunoglobulin domains and is not closely related to any other known member of this 
family (Snow et al., 1989). Fasciclin I, on the other hand, has a novel sequence that is 
unrelated to previously known molecules (Zinn et al., 1988 ). 
To begin a genetic analysis of these molecules, mutations were identified in these four 
genes (Bieber et al., 1989; Elkins et al., 1990b; Grenningloh et aI., 1990). At the gross 
level, the overall structure of the CNS in embryos develops in a relatively normal way. 
Recently, fasciclin II mutant embryos were characterized to have a defect in the MPI 
pathway by using a specific monoclonal antibody (Grenningloh et aI., 1991). In addition, 
double mutants of fasciclin I and the Abelson (abl) tyrosine kinase gene produce a lethal 
phenotype and show significant disruption in axonal organization (Elkins et al., 1990b). 
The CNS phenotypes of these null mutations suggest that fasciclins are involved in growth 
cone guidance. 
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Drosophila integrin-related proteins were first identified in the early 1980s when 
Wilcox et al. (1981) and Brower et al. (1984) found that three monoclonal antibodies 
immunoprecipitated a related group of cell surface antigens called PS 1, PS2 and PS3, 
which are expressed in restricted regions of the Drosophila imaginal wing disc. However, 
it was not until 1987 that PS antigen complexes were demonstrated to be related to 
vertebrate integrins using N-terminal sequencing (Leptin et aI., 1987). The genes encoding 
PS integrins were cloned and sequenced, which revealed a strong homology to vertebrate 
integrin sequences (Bogaert et al., 1987; MacKrell et aI., 1988). PS 1 and PS2 consist of 
two different Drosophila integrin a-subunits, called PS la and PS2a, whereas PS3 is an 
integrin ~-subunit, called PS3~, which dimerizes with the PS 1 a and PS2a subunits to form 
the PS 1 and PS2 integrin complexes. The PS antigen ligands have not yet been identified. 
ECM molecules such as laminin (Fessler et aI., 1987; Chi and Hui, 1989; Montell and 
Goodman, 1988; 1989) have been isolated and sequenced, and they are homologous to 
vertebrate counterparts. Genetic analysis of Drosophila integrin (PS3~) showed defects in 
muscle attachments and in germ band retraction (Newman and Wright, 1981; Leptin, 
1989), indicating a role in tissue morphogenesis for integrins. 
To identify cadherin-like molecules in Drosophila, degenerate oligonucleotide primers 
for PCR were used to search Drosophila cadherin domains (Mahoney et al., 1991). Two 
different cadherin genes were cloned, thefat gene (Mahoney et al., 1991) and the dachsous 
gene (Clark et aI., unpublished). The fat gene encodes a protein that contains a putative 
signal sequence 34 tandem cadherin domains, four EGF-like repeats, a transmembrane 
domain, and a novel cytoplasmic domain that is unrelated to that found in the known 
vertebrate cadherins (Mahoney et aI., 1991). Recessive lethal mutations in the fat locus of 
Drosophila result in hyperplastic, tumor-like overgrowth of larval imaginal discs and 
alterations in imaginal disc morphogenesis (Bryant et aI., 1988), suggesting its function as 
a tumor-suppressor gene. Given all of these differences, the enormous transmembrane 
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protein encoded by the fat gene is probably not the Drosophila homologue of one of the 
known vertebrate cadherins. Instead, it may represent a new type of cadherin-like molecule 
of a much larger size. Whether a true vertebrate cadherin exists in Drosophila is still 
unknown. Other adhesion molecules with EGF-repeats, leucine-rich repeats and serine-
esterase domain have been cloned and characterized (reviewed by Hortsch and Goodman, 
1991). None of them is involved in neuronal development, thus not included in this 
discussion. 
To test the adhesive properties of Drosophila surface molecules, a tissue culture 
approach was developed, using the Drosophila Schneider 2 (S2) cell line that grows as a 
single cell suspension. The idea is to transfect cloned cDNA encoding adhesion molecules 
into S2 cells under the control of an inducible promoter and then examine if large cell 
aggregates are formed after induction (Fig. 7). The ability to confer cell aggregation is 
presumably attributed to the potential adhesive properties of this molecule. This type of 
experiment was originally established by Takeichi and his colleagues to test the homophilic 
activities of cadherins (Nagafuchi et al., 1987) and was adapted to test the adhesive 
activities of Drosophila fascic1in III (Snow et al., 1989). Many molecules are defined as 
homophilic using this assay; fasciclin III (Snow et aI., 1989), fasciclin II, neuroglian 
(Grenningloh et al., 1990), fascic1in I (Elkins et al., 1990a), and chaoptin (Krantz and 
Zipursky, 1990). Notch and Delta, molecules with EGF repeats, on the other hand, can 
interact with each other in a heterophilic fashion (Fehon et al., 1990). 
The initial identification of mutations in genes encoding these molecules that have 
adhesive properties using tissue culture approaches revealed that members of gene families 
can serve different functions in neuronal development. For example, a null mutation in 
fascic1in II prevents the formation of the MP1 axon pathway, and double mutants of 
fasciclin I and Abelson tyrosine kinase gene result in a lethal phenotype with severe defects 
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in eNS, suggesting their roles in growth cone guidance. Moreover, null mutations in PS-
integrins have a defect in muscle attachments as well as in genn band retraction. The 
diversity of extracellular motifs and domains found in adhesion molecules, their alternative 
modes of membrane attachment (transmembrane or PI-linked), and their multiple 
cytoplasmic domains, suggest that adhesion molecules may play a role in specific cell 
signaling as well as in simple adhesion. We do not understand how these molecules might 
function in growth cone guidance at a molecular level. One of the strengths of a genetic 
approach to this problem is the opportunity to use enhancer and suppressor mutant screens 
to identify downstream genes that might reveal the intracellular consequences of receptor 
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Fig. 7. Schematic diagram showing the strategy of cell aggregation assays. The 
eDNA clones under heat shock promoter of these molecules were transfected into 
Schneider 2 cells, induced by heat shock and then were tested positive for their ability to 
confer cell aggregation. Using this method, several Drosophila cell surface molecules have 
been shown to be cell adhesion molecules (Snow et al., 1989). 
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III. Fasciclin I 
A. Primary Structure 
The fasciclin I protein was first identified in the grasshopper embryo as a result in a 
monoclonal antibody screen for surface antigens expressed on subsets ofaxons. It is 
expressed on the surface of all PNS axons, a subset of fasciculating CNS axons, and on 
some nonneuronal cells during development (Bastiani et aI., 1987). Subsequently, 
grasshopper fasciclin I was cloned and sequenced using oligonucleotide probes encoding 
N-terminal amino acid sequences of affinity purified proteins (Zinn et aI., 1988; Snow et 
aI., 1989). Using this clone in a low stringency screen, a cDNA encoding the Drosophila 
fasciclin I homologue was then isolated (Zinn et aI., 1988). 
Analysis of cDNAs of grasshopper and Drosophila fasciclin I proteins predicts that 
they have four homologous domains, each of approximately 150 amino acids (Fig. 8). 
Fasciclin I is a highly glycosylated protein: four potential N-linked glycosylation sites are in 
Drosophila fasciclin I, while six potential N-linked glycosylation sites are in grasshopper 
fasciclin I (Zinn et aI., 1988). Drosophila fasciclin I is a 72 kDa protein and grasshopper 
fasciclin I is a 75 kDa molecule without disulfide bonds (Snow et aI., 1989; Hortsch and 
Goodman, 1990). Fasciclin I is associated with the membrane via a phosphatidyl-inositol 
(PI) lipid anchor which can be cleaved by PI-specific phospholipase C (PI-PLC) (Snow et 
aI., 1989; Hortsch and Goodman, 1990). The last C-terminal 30 amino acids of the 
sequence are mainly uncharged and provide the signal for this protein modification. In 
fact, a variety of cell-surface proteins are found to be attached to the cell membrane via a 
PI-anchor. These include neuronal proteins such as T-cadherin, Thy-I, TAGl, isoforms 
of fasciclin II, and NCAM, as well as proteins of the immune system such asCD59, 
CD55, CD48 and Ly 6 (reviews by Low, 1989; Walsh and Doherty, 1991). These 
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molecules have been implicated in neuronal development events and in lymphocyte 
activation after crosslinking with ligand or antibody. However, it is not known how these 
molecules, which lack intracellular domains, can transduce signals. An interaction of OPI-
linked molecules with protein tyrosine kinase has been observed (Stefanova et al., 1991). 
Other mechanisms have also been proposed such as a relatively high lateral mobility in 
membranes, OPI anchor degradation and protein release by endogenous enzymes. 
However, it is still not known what is the biological significance of this anchor present in a 
large number of cell surface proteins. 
B. Adhesion Properties of Fasciclin I 
Does fasciclin I function as a neural cell adhesion molecule? This question is 
addressed by tissue culture experiments as described in the last section (Fig. 7). 
Transfection of Drosophila fasciclin I eDNA under the heat shock promoter into the S2 cell 
line followed by aggregation assays indicates that fasciclin I may be a calcium-independent 
homophilic adhesion molecule (Elkins et al., 1990a). When cells expressing fasciclin I are 
mixed with S2 cells expressing fasciclin ill, the cells sort into separate aggregates for either 
fasciclin 1- or fasciclin III-expressing cells, indicating the ability of fasciclin I to mediate 
selective cell sorting (Elkins et al., 1990a). 
Recently, Jay and Keshishian (1990) demonstrated that grasshopper fasciclin I may be 
involved in axon fasciculation using a new technique, chromophore-assisted laser 
inactivation (CALI). Fasciclin I protein on the surface of the two pioneer neurons (Til) in 
the developing grasshopper limb was selectively inactivated using this method, which 
resulted in defasciculation without affecting their growth or guidance. This result agrees 
with the labeled pathways hypothesis that fasciclin I may function as a specific cue for 
neuronal recognition during the CNS development. However, a null mutation in fasciclin I 
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gene in Drosophila does not display gross defects in axon fasciculation in the developing 
PNS (Elkins et al., 1990b). Possibly, fasciclin I plays a role in one of the redundant 
pathways. Alternatively, CALI might inactivate complexes near fasciclin I in a different 
way than in a protein null mutation. 
Grasshopper Fasciclin I Drosophilil Fasciclin I 
GlcNH 2-2 ~ PI 
~-PLC 
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Fig. 8. Schematic diagram showing the primary structure of fasciclin I The protein 
comprises four homologous domains of approximately 150 amino acids each and is 
anchored in the membrane by glycophosphatidylinositol (GPI) that can be cleaved by GPI-
specific phospholipase C (PI-PLC) indicated by an arrow. Cysteine residue is represented 
as Sand N-linked potential glycosylation site is denoted as ~. EtN, ethanolamine; P, 
phosphate; glycan, formed by varying size of galscotose and probably attached to the core 
mannose; and GlcNH2, glucosamine. 
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C. Fasciclin I May Be Involved in a Signal Transduction Pathway 
A genetic analysis of Drosophila fasciclin I was done to determine its in vivo 
functions (Elkins et al., 1990b). It appears that a null mutation in the fasciclin I gene does 
not cause lethality, and that the overall structure of the central nervous system (eNS) in 
embryos develops in a relatively normal way, which is the same for mutations in fasciclin 
II gene and fasciclin III gene as discussed above (Grenningloh et aI., 1990; Elkins et al., 
unpublished data). Recently, fasciclin II mutant embryos were characterized to have a 
defect in the MP1 pathway by using a specific monoclonal antibody (Grenningloh et al., 
1991). It is thus possible that better probes may be needed to define a specific defect in 
fasciclin I mutants. Alternatively, fasciclin I may function in one of the redundant 
pathways and thus fasciclin I mutants alone do not have a visible embryonic phenotype. In 
an attempt to explore other molecules together with fasciclin I to be involved in the process 
of growth cone extension, double mutant combinations in a fasciclin I mutant background 
were analyzed. One of the double mutants eliminating expression of both fasciclin I and 
the Abelson (abl) tyrosine kinase gene produces a lethal phenotype having a significant 
disruption in axonal organization (Elkins et al., 1990b). It is known that Abelson tyrosine 
kinase protein is a membrane-bound cytoplasmic tyrosine kinase which may act as a 
signaling molecule (Hoffmann et aI., 1983; Gertler et aI., 1989). Therefore, this result 
suggests that fasciclin I and abelson tyrosine kinase may be involved in "parallel" signal 
transducing pathways associated with growth cone movement. 
Although fasciclin I may function in selective fasciculation as well as signal 
transduction during axonal guidance, it is unclear how it works at a molecular level. The 
common picture emerging from all other adhesion molecules is that repeated structural 
motifs are often found in different gene families. Thus far, there is no structural 
information at atomic resolution of cell adhesion molecules involved in neuronal 
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recognition. We are therefore interested to study the structure-function relationships of 
fasciclin I. As a first step toward this goal, we have focused on obtaining biochemical 
quantities of protein, since fasciclin I is a rare protein in insect embryos. In Chapter 2, we 
report the establishment of Chinese Hamster Ovary (CHO) cell lines that express large 
quantities of fasciclin I using a glutamine-synthetase-based amplifiable expression system. 
Since fasciclin I is attached to the cell surface by a PI linkage, a soluble form can be derived 
by treatment with PI-PLC. Identification, purification and characterization of the soluble 
form of grasshopper fascic1in I will be discussed. The purified grasshopper fasciclin I can 
be crystallized in space group C222/. However, the crystals diffract anisotropically, with 
diffraction to 3.5 A resolution in one direction, and diffraction in the other two directions to 
only 5 A resolution. To improve the quality of crystals, several strategies were used: (i) to 
remove extra carbohydrates by glycosidases. Grasshopper fascic1in I expressed in CHO 
cells has an extra 15 kDa of carbohydrate which may impede crystallization; (ii) to remove 
the remainder of the PI tail by genetic engineering; (iii) to express a secreted form of 
fascic1in I in insect expression system; (iv) to explore other crystallization conditions. In 
Chapter 3, we report the expression of secreted form in CHO cells and in insect cells. 
Biochemical and function studies of this protein will be discussed. Lastly, the preliminary 
structural studies of grasshopper fasciclin I by x-ray crystallography will be described in 
Chapter 4. Parts of the contents of Chapter 2 to Chapter 4 are described in a manuscript in 
preparation (W.-C. W., K. Z., and P. J. B.) to be submitted to J. Bio. Chern. 
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CHAPTER 2 
EXPRESSION, IDENTIFICATION, PURIFICATION AND 
CHARACTERIZA TION OF F ASCICLIN I 
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Abstract 
To facilitate a structure-function analysis of fasciclin I, a glutamine synthetase-based 
expression system was developed. Chinese Hamster Ovary (CHO) cells were transfected 
with the full-length cDNA of fasciclin I along with a dominant selectable marker gene, the 
glutamine synthetase gene. With increasing concentrations of methionine sulfoximine, a 
potent inhibitor of glutamine synthetase gene function, stable transformant lines were 
selected and amplified. Using this system, fasciclin I, an insect molecule that is anchored 
to the membrane by a glycosyl phosphatidylinositollinkage, was expressed in a lipid form 
at high levels on the surface of mammalian cells. A soluble form of fasciclin I was 
obtained by treatment of intact CHO cells with phosphatidylinositol-specific phospholipase 
C. This CHO-derived fasciclin I molecule contains an extra 15 kDa of carbohydrate not 
found on fasciclin I from insect embryos. Milligram quantities of soluble expressed 
fasciclin I have been purified on an immunoaffinity column. Biochemical characterization 




Crystallization of any protein requires a large amount of that protein (at least 5 mg to 
start with) in a biochemically pure and functionally active state. Fasciclin I is a very rare 
protein; only 100 J..I.g can be obtainable from 1 kg of embryos. To overcome this problem, 
it is necessary to develop a system to express the protein at high levels. Although bacterial 
expression systems, such as pET-3 T7 expression vectors (Studier et al., 1990), are 
known to produce milligram quantities of expressed protein, the protein is usually 
aggregated in the form of inclusion bodies, from which it is difficult to obtain high yields 
of properly folded protein. Thus, we have chosen to express fasciclin I in eukaryotic cells, 
using a glutamine-synthetase-based amplifiable expression system developed in Celltech, 
Berkshire, U. K. (Bebbington, and Hentschel, 1987). This expression system allows 
amplification of the transfected gene in the presence of a potent inhibitor of glutamine 
synthetase, methionine sulfoximine (MSX), thereby increasing the levels of protein 
expression. 
In this chapter, the establishment of stable cell lines that express either grasshopper 
fasciclin I or Drosophila fasciclin I at high levels will be described. We show that 
grasshopper and Drosophila fasciclin I can be expressed in a GPI-linked form on the 
surface of mammalian cells, and can be cleaved quantitatively by phosphatidylinositol-
specific phospholipase C (PI-PLC). The molecule contains an extra 15 kDa of 
carbohydrate not found on fasciclin I from insect embryos. Up to 1 mg of soluble 
grasshopper fasciclin I protein per daily harvest from a cell line grown on a hollow-fiber 
bioreactor device has been purified by immunoaffinity chromatography. Finally, we will 
report some biochemical characterization of the purified grasshopper fasciclin I, including 
characterization of glycosylation heterogeneity and proteolytic resistance. 
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II. Materials and Methods 
Reagents. Restriction enzymes, Klenow fragment and T4 DNA ligase were obtained 
from Stratagene, Boehringer Mannheim or New England Biolabs. Endoglycosidase F/N-
glycosidase F, neuraminedase, and endo H glycosidase were from Boehringer Mannheim. 
6D8, a mouse monoclonal antibody (MAb) against Drosophila fasciclin I and 3B11, a 
mouse monoclonal antibody against native grasshopper fasciclin I. The 3B 11 hybridoma 
cell line that produces 3B 11, a mouse monoclonal antibody against grasshopper fasciclin I, 
and rat anti-grasshopper fasciclin I antiserum were gifts of Michael J. Bastiani (University 
of Utah). The ascites of the 3B 11 antibodies were from Monoclonal Antibody Facility at 
CaItech. Goat anti-mouse fluorescein-conjugated IgG and goat anti-mouse IgG-peroxidase 
conjugate were from Cappel Products. Mouse anti-rat IgG-alkaline phosphatase conjugate 
for Western blots was from Boehringer Mannheim. Anti-mouse Elite ABC kits for 
immunoblots were from Vector Lab. Affi-gel protein A agarose was from Bio-Rad. 
Protein A-Sepharose was from Pharmacia. Methionine sulfoximine (MSX), phospholipase 
C were from Sigma. Dulbecco's modified Eagle's medium (DMEM), a-minimum essential 
medium (aMEM), fetal bovine serum (FBS), dialyzed fetal bovine serum (DFBS), 
geneticin (G418) and other chemicals for tissue culture were from Sigma, Irvine Scientific 
and GIBCO/BRL. 
Construction of lipid-linked forms of grasshopper fasciclin I and 
Drosophilll fasciclin I. Full-length cDNA clones encoding the surface protein fasciclin 
I from grasshopper and Drosophila (Zinn et al., 1988) were subcloned into the EcoRI site 
of the polylinker of two expression vectors pBn and pBJ5 (Lin et aI., 1990), respectively, 
to generate four plasmids pBJ1.Dfl, pBJ5.Dfl, pBJ1.Gfl, and pBJ5.Gfl (Fig. 1). Dfl 
represents Drosophila fasciclin I and Gfl represents grasshopper fasciclin I. pBJl and 
pBJ5 both contain the SRa promoter (Take be et al., 1988) composed of the SV 40 early 
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promoter and the R-U5 segment of the human T-cell leukemia virus type 1 (HTLV-l) long 
terminal repeats. This promoter is 1 or 2 orders of magnitude more active than the SV 40 
early promoter (Take be et al., 1988). The major difference of these two vectors is that 
pBJ5 has a 16S splice junction while pBJ1 does not. 
Amp;;:; 
pBJ1.f1 pBJ5.f1 
Fig. 1. Expression vectors pBI1.fl and pBI5.fl. pBIl.f1 and pBJ5.fl are composed of 
the full-length cDNAs of either Drosophila fasciclin I (3 Kb) or grasshopper fasciclin I 
(3.16 Kb) under the control of SRa. The construction was done by EcoRI fragment 
containing fasciclin I cDNA into the EcoR! site of the polylinker of pBn or pBI5. 
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Fig. 2. Construction of pBJ5.GS.fl. pBJ5.GS.Dfl and pBJ5.GS.Gfl contain the full-
length cDNAs of fasciclin I (Drosophila or grasshopper) under the control of SRa. and the 
glutamine synthetase minigene from pSVLGS.1. 
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The glutamine synthetase (GS) minigene from the Celltech vector pSVLGS.l was 
excised using AatII and BamHI, the ends filled in using T4 polymerase and the resulting 
fragment was blunt end cloned into the filled in XhoI site of pBluescript KS(+) 
(Stratagene). A 5.5 Kb XhoI-SalI fragment containing the GS minigene was then cloned 
into the unique SalI site of pBJ5.Dfl to generate pBJ5.GS.Dfl, or into one of the two SalI 
sites of pBJ5.Gfl in a partial digest to obtain pBJ5.GS.Gfl (Fig. 2). Molecular biological 
experiments were perfonned by standard methods (Sambrook et al., 1989). 
Cell culture and transfection. COS7 cells were grown in monolayer culture in 
Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 2 mM 
glutamine and 100 U/ml of penicillin/streptomycin (Gibco Labs, or Irvine Scientific). 
Chinese Hamster Ovary (CHO) Kl cells were grown in aM EM supplemented with 10% 
FBS,2 mM glutamine and 100 U/ml penicillin/streptomycin. 
For transient transfections, COS7 cells were transfected by the DEAE-dextran method 
(12 mg DNA/ 60 mm 70% confluent plate) (Gorman, 1985; Ausubel et aI., 1989). Mock 
transfection was performed without plasmid DNA. A 10% DMSO shock for 2 minutes 
following transfection with DEAE-dextran was employed to increase expression levels. 
Three days after transfection, the cells were harvested, washed with PBS and suspended in 
PBS or homogenization buffer (20 mM Tris, pH 7.5, 1 mM Imidazole, 1 mM DTT, 1 mM 
magnesium chloride, 20 mM sodium diphosphate, protease inhibitor cocktail). The cell 
extracts then were either subjected to a CAT assay (Gorman et al., 1982) to determine the 
effectiveness of the transient transfection, or were prepared for Western blot analysis. 
For stable transfection using the GS-based system, pBJ5.Dfl.GS and pBJ5.Gfl.GS 
were introduced into CHO cells respectively by lipofectin-mediated method (FeIgner et al., 
1987). Selection and amplification of the glutamine synthetase gene were carried out 
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mainly according to the protocol established by Celltech. In brief, 200 ~l of DNA-
lipofectin complexes (30 ~g DNA plus 80-100 ~g of lipofectin) were introduced into a 10-
cm plate with SO% confluent cells cultured in 1 % DFBS, aMEM without glutamine. After 
18-24 hours of incubation at 370C, the medium was replaced with 10% DFCS, aMEM 
without glutamine and incubation continued for an additional 24 hours. The cells were then 
split into six 96-well plates and selected with IS to 30 ~ of MSX in 10% DFBS, aMEM 
without glutamine. MSX-resistant clones appeared and were isolated about 2 weeks later. 
The positive transfectants were recloned and amplified under l00-S00 ~ of MSX in 10% 
DFBS, aMEM without glutamine. The highest expressing cell populations were then 
selected by immunofluorescence with 3B 11 or by a flow cytometeric analysis with cells 
stained with 3B 11. The highest expressing lines were grown in a Cell Phann I hollow-
fiber bioreactor device (Unisyn Fibertec, San Diego; Fig. 3), allowing growth of up to 
1011 cells in a 2S0-ml bioreactor. 
Cell staining. Fixed cell staining was done by fixing cells in a solution of 
methanol:acetone (1: I) for 2 minutes. After being washed ,with PBS; the cells were 
incubated with the primary antibody solution (dilution of 1 :200 to 1 :SOO with PBS 
containing 3% BSA) for 1 hour at 2SoC and washed thoroughly with PBS. Either 
horseradish-peroxidase conjugated or fluorescently labeled goat anti-mouse antibody 
(Cappel Labs) was then added to the cells at a dilution of 1:100 (in PBS, 3% BSA). The 
cells were developed by DAB-peroxide hydrogen solution as described previously if 
horseradish peroxidase-conjugated secondary antibody was used. 
Alternatively, live cell staining was perfonned in essentially the same manner as above, 
except that all procedures were carried out at 40C and cells were not treated with 
methanol:acetone. Cells were observed under an inverted microscope equipped with 
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view along A 
Fig. 3. Schematic diagram of a Cell Pharm II hollow-fiber bioreactor (Unisyn Fibertec, 
San Diego). 
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Gel electrophoresis, isoelectric focusing, and Western blot analysis. 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SOS-PAGE) was performed 
according to Laemmli (1972) and silver staining was performed essentially according to 
Morrissey (1981). Isoelectric focusing was performed as described in Giulian et al. 
(1984). 
After SOS-PAGE, proteins were blotted to nitrocellulose paper according to Towbin et 
al. (1979). Protein transfer was done at 100 V for 3 hours in transfer buffer (25 mM Tris, 
190 mM glycine, to% methanol). The blots with transferred proteins were immersed in 
5% non-fat dry milk in TBST solution (to mM Tris-HCI, pH 8.0, 150 mM NaCI, 0.05% 
Tween 20) for 30 minutes and then incubated with mouse anti-Drosophila fascic1in I MAb 
(608), or rat (or mouse) anti-grasshopper fascic1in I antiserum at dilution of 1 :1000 with 
TBST. After 1 hour, the blots were washed three times with TBST, two times with TBS 
(10 mM Tris-HCI, pH 8.0, 150 mM NaCl), each for to-IS minutes and incubated with 
affinity-purified horseradish-peroxidase-conjugated goat anti-mouse or rat-anti-mouse IgG 
(l :200, diluted with TBS, Cappel) for 30 minutes. After three washes with TBS, twice 
with PBS and once with 50 mM Tris, pH 7.6, the blots were visualized using 
diaminobenzidine (DAB)-hydrogen peroxide staining solution [0.06% OAB (w/v), 0.03% 
H20Z (v/v) in 50 mM Tris, pH 7.6] until the bands were suitably dark (about 5 minutes). 
Alternatively, Elite ABC kits for immunoblots from Vector Lab were used. All procedures 
were carried out at room temperature. 
Flow cytometric analysis. Trypsinized cells (2x t06 cells per sample) were 
incubated with MAbs in ascites fluid at a dilution of 1: 100 at least 15 minutes on ice, 
washed three times with PBS and incubated with fluorescein conjugated goat anti-mouse 
IgG. After 15 minutes, cells were washed three times with PBS, resuspended in 1 mlof 
PBS containing 0.02% sodium azide and passed through a 50 JJ.M filter. Flow cytometric 
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analysis was carried out on Ortho Cytofluorograf 50H with a Data General 2150 Computer 
System. 
Deglycosylation of membrane proteins and phospholipase C treatment. 
Protein from transfected cells and from 10 to 14 hr old of Drosophila embryos were 
deglycosylated with en do glycosidase F carried out according to the manufacturer's 
specifications (Boehringer Mannheim Biochemica). Deglycosylated protein was analyzed 
on Western blots. 
For analytical assays, PI-PLC from Bacillus cereus (Boehringer Mannheim 
Biochemica) was added to a final concentration of 1 Vlml, incubated for 1 hour at 370C 
and the solution was centrifuged. For releasing fasciclin I from cells grown in the hollow 
fiber bioreactor device, phospholipase C containing PI-PLC (Sigma P6135; 1 mglml) was 
injected into the cell site at a 50-fold dilution for 3 hours at 37OC. 
Cold immunoprecipitation, 3SS metabolic labeling, and N-terminal 
amino acid sequencing. Positive cell transfectants expressing PI-linked grasshopper 
fasciclin I were washed and digested with PI-PLC as described above. Supernatants 
containing fasciclin I were then reacted with 3B II-protein A beads for 2 hours at room 
temperature with a gentle agitation (in a nutator). The imrnunoprecipitates were washed six 
times with PBS and were electrophoresed on 10% SDS-PAGE. 
For metabolic labeling, 1()5 transfected cells expressing PI-linked grasshopper fasciclin 
I were cultured overnight with 100 ~Ci 35S methionine. Cells were then washed and 
digested with PI-PLC. The resultant supernatants were concentrated 10 fold and were 
electrophoresed on 10% SDS-PAGE. Gels were then fixed and prepared for 
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autoradiography using the EN3HANCETM system according to the manufacturer's 
directions (Dupont). 
For N-terminal sequencing, cells of two 175-cm2 flasks were washed thoroughly and 
treated with PI-PLC and the supernatants were concentrated 30 fold on a centricon (30K 
cut off). The protein was isolated on a 10% SDS PAGE gel and electroblotted in a Bio-
Rad transblot system onto a polyvinylidede difluoride membrane (PVDF, Millipore) and 
inserted in an Applied Biosystems Model 4778 sequencer reaction catridge. 
Purification of soluble grasshopper fasciclin I by a 3811 
immunoaffinity chromatography and the anionic Mono Q column. The 3Bll-
protein A coupled immunoaffinity column was prepared essentially according to Harlow 
and Lane (1988). Briefly, 6 ml of 3Bll ascites (2 mg/ml of 3Bll) were adjusted to pH 
9.0, 3 M NaCI and then reacted with 5 ml of protein A beads (Pharmacia or Bio-Rad) for 
1-2 hours in a nutator. After coupling, beads were washed thoroughly with 50 mM 
sodium borate, 3 M NaCl, pH 9.0 for four times and were resuspended in 10 volumes of 
0.2 M sodium borate, 3 M NaCI, pH 9.0. Crosslinking of 3B 11 and protein A beads was 
done using 20 mM of dimethyl pimelimidate (DMP, Pierce) in 0.2 M sodium borate, 3M 
NaCI, pH 9.0 for 30 minutes. The reaction was stopped by washing once in 0.2 M 
ethanolamine (pH 8.0) and incubation was continued for an additional 2 hours. The beads 
were washed three times with phosphate buffer saline (PBS) and resuspended in PBS with 
0.04% sodium azide. All the procedures were carried out at room temperature. 
To purify grasshopper fasciclin I, supernatants (about 500 ml) were passed over the 
column at a flow rate of 20 ml/hr at 4OC, and the column was washed with 500 ml of PBS, 
0.05% sodium azide. The fasciclin I protein was then eluted by 0.1 M sodium acetate, pH 
3.4. Fractions of 3 mt were collected in test tubes containing 0.5 mt of 1 M phosphate, pH 
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8.2 to neutralize the elution buffer immediately. Generally, about 1 mg of grasshopper 
fasciclin I was obtained per daily harvest from the Cell Phann containing a 250-ml hollow-
fiber bioreactor. 
For further purification, a solution of protein in 20 mM bisTris propane (pH 7.2) was 
applied on an FPLC Mono Q column preequilibrated with the same buffer, and eluted with 
a gradient of N aCt salt (0-150 mM) at a flow rate 1 mVmin. All procedures were 
performed at room temperature. 
Proteolysis. Purified grasshopper fasciclin I expressed in CHO cells was treated with 
a battery of proteases, including trypsin, chymotrypsin, elastase, and papain. Protein was 
mixed with each protease at a 100:1 mass ratio in phosphate buffered saline (PBS) solution 
and incubated at 370 C. Aliquots of digested mixture were withdrawn at different time 
intervals, for example, 0, 30, 60 and 120 minutes, and the reaction was stopped by adding 
immediately phenylmethanesulfonyl fluoride (PMSF). 
Deglycosylation by treatment with neuraminidase, endo Hand endo F. 
Purified soluble grasshopper fasciclin I (400 Jlg) was added with different glycosidases in 
reaction conditions suggested by the Boehringer Mannheim manual: 0.1 U of 
neuraminidase (Sigma) in PBS, 0.2 U of endo H in 50 mM sodium phospate (pH 5.5), 
and 2 U of endo F in 0.25 M acetate (pH 6-7) and incubated at 4<>C, room temperature or 
370C. Progress of the reaction was monitored as a size decrease on 10% SDS-PAGE by 
withdrawing aliquots of reaction mixture at different time intervals. 
Size-exclusion chromatography and anionic chromatography. Following 
immunoaffinity chromatography, purified grasshopper fasciclin I was concentrated 
approximately 0.2-1 mg/ml using a vacuum dialysis apparatus (Schleicher & Schuell) and a 
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Centricon centrifugal concentrator (Amicon, 25 K cut). Fifty ml of the concentrated protein 
was subjected to a Superose 12 fast pressure liquid chromatography (FPLC) column 
equilibrated with PBS. 
Purified grasshopper fasciclin I from CHO cells (0.2-1 mg/ml) was dialyzed against 20 
mM bisTris propane, pH 7.2 and then loaded onto a 1 ml Mono-Q Sepharose fast pressure 
liquid chromatography anion-exchange chromatography preequibibrated with 20 mM 
bisTris propane (pH 7.2). Grasshopper fasciclin I was eluted with a salt gradient from 20 
mM bisTris propane (pH 7.2) to 1 M NaCl, 20 mM bisTris propane (pH 7.2). 
III. Results 
A. Expression of PI-linked Form of Fasciclin I in Chinese Hamster Ovary 
(CHO) Cells 
To express fasciclin I in mammalian cells, full-length cDNAs encoding the 
grasshopper and Drosophila fasciclin I proteins (Zinn et al., 1988) were subcloned into the 
expression vectors, pBJl and pBJ5 (Takebe et al., 1988; Lin et aI., 1990) which contain a 
strong SV40/HTLV-l hybrid promoter, as well as the SV40 origin of replication. To 
examine if fasciclin I was properly expressed under the SRa promoter, these four 
plasmids, pBJl.Dfl, pBJ5.Dfl, pBJI.Gfl, and pBJ5.Gfl (Fig. 1), were transiently 
transfected into COS7 cells, in which plasmids bearing SV 40 origins are efficiently 
replicated. Plasmid pSV2CAT was also transfected into COS7 cells to examine the 
transfection efficiency using a CAT assay (Fig. 4). After 3 days, the transfected cells were 
analyzed by CAT activity, or by immunofluorescent staining with the MAb 3Bll, which 
recognizes grasshopper fasciclin I in live cell staining, or with the MAb 6D8, which 
recognizes Drosophila fasciclin I in fixed cell staining. As shown in Fig. 4, CAT activity 
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was observed, indicating that the transfection was successful. 1-5% of the cells displayed 
bright surface staining (data not shown). Membrane proteins of COS7 cells were analyzed 
by Western blotting with the MAb 6D8, which recognized Drosophila fasciclin 1. It 
appeared that the expressed Drosophila fasciclin I in COS7 cells migrated at an apparent 
weight of 85 kDa compared to -72 kDa to the Drosophila embryo fasciclin I (Fig. 5). After 
deglycosylation with endoglycosidase F (endo F), Drosophila fasciclin I protein from either 
COS7 cells or from embryos migrated at the same position, indicating the anomalous 
migration in the expressed fasciclin I is due to a higher extent of glycosylation in COS7 
cells. To detennine if fasciclin I can be released from the trasfected cells by PI-PLC, 
transfected COS7 cells were treated with PI-PLC, and samples of supernatant and 
membranes were analyzed for the presence of fasciclin I by Western blotting with the MAb 
6D8. Almost all of the fasciclin I appeared in the supernatant fraction, indicating that most 
of the fasciclin I could be released from the transfected cells by PI-PLC (Fig. 6). 
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Fig. 4. Effectiveness of transfection into COS? cells by CAT assays. COS? cells were 
transfected with pSV2CA T (lanes 4 and 5), or cotransfected with pSV2CAT and pBl5.Dft 
(lanes 6 and ?) using DEAE-dextran method. Lanes 1 and 2 were non-transfected cell 
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Fig. 5. Western blotting analysis of deglycosylated fasciclin I from transfected COS7 cells 
or from Drosophila embryos. Membrane fractions from transiently transfected COS7 cells 
(n with pBJ5.Dfl or from 10 to 15 hr Drosophila embryos (D) were treated with endo F 
for 0 to 24 hr as indicated. Digested proteins were subjected to 10% SDS-PAGE and 
fasciclin I protein was detected on Western blots by the MAb 6D8. 
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Fig. 6. Western blotting analysis ofPI-PLC released Drosophila fasciclin I from transiently 
transfected COS7 cells with pBJ5.Dfl or from membrane fractions of Drosophila embryo. 
Membrane fractions prepared from transfected COS7 cells (T, T*) , from mock transfected 
COS7 cells (C, C*) or from 10 to 14 hr old Drosophila embryos (D, D*) were treat~ with 
PI-PLC. Membrane pellets (M) and supernatants (S) were isolated after digestion with PI-
PLC, separated on a 10% SDS-PAGE, and analyzed by Western blotting. T*, C* and D* 
were incubated with PI-PLC, whereas T, C, and D were not. 
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After demonstrating that fasciclin I could be expressed on the surface of mammalian 
cells, stable transformant lines were created in Chinese Hamster Ovary (CHO) cells using a 
glutamine-synthetase-based amplifiable expression system developed by Cell tech 
(Bebbington and Hentschel, 1987). This system allows selection and amplification of the 
transfected genes in the presence of the drug, methionine sulfoxime (MSX). Two plasmids 
pBJ5.Dfl.GS and pBJ5.Gfl.GS (Fig. 2) were created by subcloning the GS minigene 
into pBJ5.Gft and pBJ5.0ft, and introduced into CHO cells. Stable transformant lines 
were selected and amplified with 15-30 J..LM of MSX. 146 MSX-resistant clones 
transfected with pBI5.0ft.GS and 88 MSX-resistant clones transfected with 
pBIS.Gft.GS were selected for further amplification with 10-fold increase in the 
concentration of MSX. Levels of amplification varied, but some clones could be grown in 
the presence of up to 800 J..LM of MSX. The positive clones expressing grasshopper 
fasciclin I were initially screened by immunostaining using the MAB 3B 11 (Fig. 7). The 
highest-expressing clone was then selected by fluorescence activated cell sorting (FACS) 
and FACS analysis showed that the fasciclin I could be released from these cells by PI-
PLC (Fig. 8). Intact cells of the highest-expressing cell line were treated with PI-PLC and 
analyzed on a 10% SOS-PAGE gel to estimate the expression level; -10 J..Lg per 107 cells 
were produced, representing 6 x 1()6 molecules per cell. The level of expression of this cell 
line remains constant for at least 2 months as analyzed by FACS. 
We were unable to analyze the Drosophila fasciclin I-expressing lines by FACS 
because none of the existing anti-fasciclin I MAbs, which had been raised against denatured 
protein expressed in E. coli (Hortsch and Goodman, 1990), were capable of staining the 
surfaces of live cells. Twenty positive clones expressing Drosophila fasciclin I were 
selected by immunostaining with the fixed cells using the MAb 608. However, we did not 
further pursue purification of Drosophila fasciclin I expressed in CHO cells since no MAbs 
could be used for purification by affinity chromatography. We have since used native 
58 
protein released from the CHO-Drosophila fasciclin I line to generate MAbs that stain live 
cells as well as bring down the Drosophila fasciclin I using immunoprecipitation (Te-Yi 
Kung and W-c. W., unpublished results). These MAbs should be useful for future 
studies. 
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Fig. 8. Flow cytometric analysis of the PI-linked grasshopper fasciclin I proteins on the 
highest-expressing CHO cell line digested with PI-PLC. Cells were treated with PI-PLC 
(0.5 V/ml) for 1 hr at 370 C, washed and immunostained with the MAb 3B 11. Dashed 
(---) line represents negative control; dotted line (-) represents sample after PI-PLC 
treattnent; solid line (-) represents the highest-expressing CHO cells. 
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B. Identification of Fasciclin I Expressed in CHO Cells 
To identify the CHO-derived grasshopper and Drosophila fasciclin I, cells were 
metabolically labeled with 35S methionine, and supernatants from cells after washing and 
PI-PLC treatment were analyzed on a 10% SDS-PAGE gel (Fig. 9). The grasshopper and 
Drosophila fasciclin I migrated with apparent molecular masses of 90 and 85 kDa 
respectively, as compared to PI-PLC released fasciclin I from insect embryos which 
migrates with an apparent molecular mass of75 kDa (grasshopper) or 72 kDa (Drosophila) 
(Snow et al., 1988; Hortsch and Goodman, 1990). Cold immunoprecipitation (using the 
MAb 3B 11) or Western blot (using a rat anti-grasshopper fasciclin I antiserum) of PI-PLC 
released proteins from CHO-grasshopper fasciclin I-expressing cells also showed a 90 kDa 
band that corresponds to grasshopper fasciclin I (Fig. 10). The 90 kDa band was isolated 
(-30 ~g) after transfer onto a PVDF membrane and subjected to N-terminal amino acid 
sequencing. The sequence obtained, KGEKSLEYKIRDDPDL, exactly corresponds to the 
first 16 residues of the mature grasshopper fasciclin I (Snow et al., 1988; Zinn et al., 
1988). The difference in molecular weight between CHO-derived grasshopper and 
Drosophila fasciclin I is probably due to the presence of six potential N-linked 
glycosylation sites in the grasshopper fasciclin I sequence, as compared to four in 
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Fig. 9. 35S metabolic labeling analysis of the expressed fasciclin I. PI-PLC released 
fasciclin I proteins (Drosophila or grasshopper) from HP transformed cells that cultured 
overnight with 35S methionine (100 !lCi), were subjected to 10% SDS-PAGE in either 
reducing (R) or nonreducing (NR) condition for autoradiography. C, original CHO cells; 
D*, transformed cell line expressing Drosophila fasciclin I; G*, transformed cell line 
expressing grasshopper fasciclin I; -, without treatment of PJ-PLC, and +, with treatment 
of PI-PLC. 
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Fig. 10. Cold immunoprecipitation of CHO-derived grasshopper fascic1in I. PI-PLC 
released material from CHO cells expressing PI-linked grasshopper fasciclin I was reacted 
with protein G-3Bll beads. The washed immunoprecipitates were subjected to a 10% 
SOS-PAGE gel. Lane 1 was without PI-PLC treatment; lane 2 (17 mVfml) and lane 3 (83 
mVfml) were with PI-PLC treatment and lane 4 was a control for interaction of 3B 11 and 
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Fig. 11 . Deglycosylation of PI-PLe released fasciclin I from eHO cells. PI-PLe released 
protein from I()4 cells were deglycosylated with endo F, subjected to 8% SDS-PAGE and 
analyzed by Western blotting using the MAb 6D8 for Drosophila fasciclin I (left) or the rat 
anti-grasshopper fasciclin I for grasshopper fasciclin I (right). e*, mock transformed cell 
line; G*, transformed cell line that expresses grasshopper fasciclin I; D*, transformed cell 
line that expresses Drosophila fasciclin I; DM, membrane fractions of Drosophila embryo; 
DS, supernatant of Drosophila embryo membrane preparations after digestion of PI-PLC. 
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Complex oligosaccharides are added to proteins synthesized in mammalian cells, as 
compared to small truncated oligosaccharide cores added to proteins synthesized in insect 
cells (Carr et al., 1989; Kuroda et al., 1990). Thus, it seemed likely that the difference in 
molecular weight between the insect and CHO-derived fasciclin I proteins was due to 
additional glycosylation in CHO cells. To examine this possibility, PI-PLC released 
proteins from CHO-derived lines were treated with endoglycosidase F and compared on a 
Western blot to similarly treated fasciclin I from Drosophila embryos. After 
deglycosylation, Drosophila fasciclin I from CHO cells comigrates with fasciclin I derived 
from embryos. Deglycosylated CHO-derived grasshopper fasciclin I also migrates at a 
similar position, corresponding to an apparent molecular mass of 68 kDa (Fig. 11). 
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C. Purification and Characterization of Grasshopper Fasciclin I 
The highest expressing CHO clones producing the PI-linked proteins were grown in 
a Cell Pharm II hollow fiber bioreactor device (Unisyn Fibertec, San Diego) in the presence 
of 300 mM MSX. The expressed protein was harvested from the medium after a 3 hour 
phospholipase C incubation (0.5 ml of 1 mg/ml) and isolated by passing over a 3B 11 MAb 
immunoaffinity column (Fig. 12). -0.7-1.0 mg of pure protein per daily harvest was 
obtained (Table 1). Purified PI-linked grasshopper fasciclin I migrates with an apparent 
molecular mass of -90 kDa (Fig. l3). 
Purification Scheme of Grasshopper Fasciclin I 
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Fig. 12. Purified scheme of grasshopper fasciclin I. 
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Fig. 13. SDS-PAGE analysis of purified grasshopper fasciclin I (pI-fonn) from CHO 
cells. PI-PLC released material from a Cell Phann I hollow-fiber bioreactor device was 
isolated by passing over a 3B 11 immunoaffinity column and eluted with acid CODditions 
(pH 3.4). Fractions (lane 1 to lane 6) containing purified fasciclin I proteins were 
subjected to 10% SDS-PAGE and visualized by coomassie brilliant blue R-250 staining. S, 
protein standards. 
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Further purification was attempted with anionic exchange chromatography using an 
FPLC Mono Q column. As shown in Fig. 14A, purified grasshopper fasciclin I after a 
3B 11 immunoaffinity column was eluted as many overlapping peaks. Fractions of these 
peaks all migrated with an apparant molecular mass of 90 kDa on a 10% SDS-PAGE gel, 
indicating that CRO-derived grasshopper fasciclin I is quite charge heterogeneous. In an 
effort to obtain a homogeneous species for crystallization, we have used step gradients of 
NaCl salt (30 mM for 5 min, 100 mM for 5 min, 125 mM for 5 min and 1M for 5 min) to 
elute fasciclin I. A major peak appeared when eluted with 100 mM salt (Fig. 14B). 
Analysis of protein of this peak on a native isoelectric focusing (IEF) gel showed a pI from 
5.5 to 6.5, as compared to pI from 5.5 to 7.5 for the CHO-derived grasshopper fasciclin I 
(Fig. 15), suggesting that CRO-derived grasshopper fasciclin I is very charge 
heterogeneous. 
In an attempt to remove the extra 15 kDa of carbohydrate in the CRO-derived 
fasciclin I, we have analyzed different glycosidases, including neuraminidase, endo R and 
endo F, to deglycosylate the purifed grasshopper fasciclin I. Deglycosylation of the protein 
with neuraminidase and endo R reduced the apparent molecular mass to -85 kDa and -75 
kDa, respectively, as shown by SDS-PAGF/1O% (Fig. 16A). Deglycosylation with endo 
F, however, resulted in three species with apparent molecular masses of 66,68, and 70, as 
well as apparent degradation of the protein. Analysis of the deglycosylated fasciclin I 
protein on a native IEF gel revealed an increasing pI from 5.5 to 7.5 with only four 
species, as compared to pI from 5.5 to 7.5 with 11 species in nondeglycosylated protein 
(Fig. 15). To optimize the reaction conditions, kinetic studies for neuraminidase and endo 





































Fig. 14. Anionic exchange chromatography of the CHO-derived grasshopper fasciclin I. 
Immunopurified grasshopper fasciclin I material was applied on an FPLC Mono Q column 
pre-equilibrated with 20 mM bisTris propane, pH 7.2 and eluted with a salt gradient 90-
150 mM NaCI (A) or step gradients, 50 mM, 100 mM, 125 mM of NaCI (B). 
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Fig. 15. Isoelectric focusing analysis of the CHO-derived grasshopper fasciclin I. PI-PLC 
released grasshopper fasciclin I from CHO transformed cells was subjected to a native 
isoelectric focusing gel. Lane 1, pure PI-form grasshopper fasciclin I treated with 
neuraminidase; lane 2, pure fascic1in I treated with endo H; lane 3, pool n after the Mono Q 
column; lane 4, the PI-form grasshopper fasciclin I purified from the immunoaffinity 
chromatography; SI, IEF standards, pI 4.6-9.6 (BioRad); S2, IEF standards, pI 2.5-6.5 
(Pharmacia). 
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Table 1. Harvest of PI-fonn grasshopper fascic1in I in the Cell Pharm III 
2 10-18-90 300 0.5 
3 10-22-90 290 1.0 
4 10-23-90 270 0.5 
5 10-24-90 240 0.8 
6 10-26-90 350 1.0 
7 10-27-90 360 0.5 
8 10-28-90 310 0.2 
9 10-29-90 185 0.2 
10 10-30-90 340 0.8 
11 10-31-90 430 0.5 
12 11-02-90 314 0.3 
13 11-04-90 316 0.9 
14 11-05-90 272 0.2 
15 11 -06-90 352 0.7 
16 11 -07-90 328 0.5 
17 11-08-90 420 0.6 
18 11-09-90 380 0.5 
19 11-11-90 340 0.3 
20 11-12-90 330 0.3 
21 11-13-90 240 0.4 
22 11-14-90 320 0.2 
23 11-15-90 360 0.3 
24 11-16-90 360 0.5 
25 11-17-90 250 0.2 
26 11-18-90 440 0.7 
27 11-20-90 220 0.4 
cel of clone expressing the highest PI-fonn grasshopper were 
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Fig. 16. Deglycosylation of the PI-form of grasshopper fasciclin by glycosidases. Pure 
proteins (lane 1) were glycosylated with neuraminidase (lane 2), endo H (lane 3) and en do 
F (lane 4) at a ratio of 1: 100 at 370C overnight (A). To optimize the reaction conditions, 
proteins were incubated with neuraminidase (B) or endo H (C) at different temperatures 
and aliquots of sample were withdrawn at different intervals as indicated for 10% SDS-
PAGE. 
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To examine the stability and possible domain snucture of purified fasciclin I, samples 
of purified protein were treated with trypsin, chymotrypsin, papain, and elastase (Fig. 17). 
Fasciclin I was resistant to digestion by these proteases, suggesting that the protein is 
folded into a stable structure without obvious flexible linker sequences between its 
domains, or that potential cleavage sites were protected by an extra 15 kDa of carbohydrate. 
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Fig. 17. Proteolytic digestion of the CHO-derived pure grasshopper fasciclin 1. Pure 
proteins were treated with elastase, trypsin, chymotrypsin and papain as indicated at 370 C. 




As a first step towards a structural and functional analysis of grasshopper fascic1in I, 
we have established mammalian cell lines that express the PI-linked grasshopper fasciclin I 
using a glutamine-synthetase-based amplifiable expression system. With this expression 
system, a high level of expression is obtained in the initial selection and amplification in the 
presence of MSX, and a much higher expression is rapidly achieved after the second-round 
amplification. Expression of grasshopper fasciclin I was detected at the cell surface of 
CRO transfected populations by flow cytometry, using a conformation-sensitive 
monoclonal antibody, 3B 11. The highest expression clone producing -10 ~g per 107 cells, 
representing 6 x 106 molecules per cell, was selected at 300 mM MSX. Staining was 
diminished by treatment of positive cell populations with PI-PLC, indicating that the CHO-
derived grasshopper fasciclin I was associated with the cell membrane by its PI anchor. 
The PI-forms of CHO-derived grasshopper fasciclin I and Drosophila fasciclin I were 
identified to have apparant molecular masses of -90 kDa and -85 kDa, respectively, as 
analyzed by cold immunoprecipitation, Western blot, 35S metabolic labeling and N-terminal 
amino acid sequencing. As compared to -75 kDa for grasshopper fasciclin I in 
grasshopper embryos (Snow et aI., 1988) and -72 kDa for Drosophila fasciclin I in 
Drosophila embryos (Hortsch and Goodman, 1990), there is an extra -15 kDa molecular 
mass. The difference in molecular weight between the insect and CHO-derived fasciclin I 
proteins was demonstrated to be due to the additional glycosylation in CHO cells (Carr et 
aI., 1989; Kuroda et aI., 1990). This is consistent with six predicted N-linked 
carbohydrate structures in grasshopper fasciclin I and four in Drosophila fasciclin I (Zinn et 
al., 1988). Up to 1 mg of pure grasshopper fasciclin I per daily harvest in a Cell Pharm 
has been obtained for further biochemical characterization (Chapter 3) and a structure 
determination (Chapter 4). 
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With large amounts of complex oligosaccharides added on proteins, CHO-derived 
grasshopper fasciclin I is characterized to be very charge heterogeneous as shown in the 
profile of an anionic exchange chromatography and an isoelectric focusing analysis. The 
extra -15 kDa carbohyrates of fasciclin I can be easily removed with different glycosidases, 
yet there are still four species with different pI after deglycosylation, probably due to 0-
linked glycosylation or other post-translational modifications. We have also shown that the 
expressed grasshopper fasciclin I is proteolytically resistant. indicating that the protein is 
not an extended structure with potential linker sequences between its domains, which is in 
contrast to a common feature suggested for adhesion molecules (Hynes and Lander, 1992). 
Alternatively. the large amount of carbohydrate attached to this protein may prevent the 
proteolytic digestion with proteases. 
75 
References 
Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., 
and Struhl, K. (1989) Introduction of DNA into mammalian cells. In Current protocols in 
molecular biology. Volume I, Chapter 9. 
Bebbington, C. R., and Hentschel, C. C. G. (1987). In DNA Cloning, ed. Glover, D. M. 
(lRL, Oxford), Vol. 3, pp. 163. 
Carr, S. A., Hemling, M. E., Folena-Wassennan, G., Sweet, R. W., Anumula, K., Barr, 
J. R., Huddleston, M. J., and Taylor, P. (1989). Protein and carbohydrate structural 
analysis of a recombinant soluble CD4 receptor by mass spectrometry. J. BioI. Chern. 264, 
21286-21295. 
FeIgner, P. L., Gader, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, 
J. P., Ringold, G. M., and Danielsen, M. (1987). Lipofection: A highly efficient, lipid-
mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84,7413-7417. 
Giulian, G. G., Moss, R. L., and Greaser, M. (1984). Analytical isoelectric focusing 
using a high-voltage vertical slab polyacrylamide gel system. Anal. Biochem. 142, 421-
436. 
Gonnan, C. (1985). High efficiency gene transfer into mammalian cells. In DNA cloning: 
A practical approach. Volume II. Ed. D. M. Glover. IRL press, Oxford. Chapter 6, pp. 
143-190. 
Gorman, C., Moffat, L. F., and Howard, B. H. (1982). Recombinant genomes which 
express chloramphenical acetyltransferase in mammalian cells. Mol. Cell BioI. 2, 1044-
1051. 
Harlow, E., and Lane, D. (1988). In Antibodies: a laboratory manual, Cold Spring Harbor 
Laboratory. Cold Spring Harbor, NY, Chapter 13. 
Hortsch, M., and Goodman, C. S. (1990). Drosophila fasciclin I, a neural cell adhesion 
molecule, has a phosphoinositol lipid membrane anchor. J. BioI. Chern. 265, 15104-
15109. 
Hynes, R. 0., and Lander, A. D. (1992). Contact and adhesive specificities in the 
associations, migrations and targeting of cells and axons. Cell 68, 303-322. 
Kunkel, T. A., Roberts, J. D., and Zakour, R. A. (1987). Rapid and efficient site directed 
mutagenesis without phenotypic selection. Meth. Enzymol. 154,367-382. 
Kuroda, K., Geyer, H., Geyer, R., Doerfler, W., and Klenk, H.-D. (1990). The 
oligosaccharides of influenza virus hemagglutinin expressed in insect cells by a 
Baculovirus vector. Viroi. 174,418-429. 
Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of 
bacterophage T4. Nature 227, 680-685. 
Lin, A. Y., Devaux, B., Green, A., Sagerstrom, C., Elliott, J. F., and Davis, M. M. 
(1990). Science 249,677-679. 
76 
Morrissey, J. H. (1981). Silver stain for proteins in polyacrylamide gels: a modified 
procedure with enhanced uniform sensitivity. Anal. Biochem. 117,307-310. 
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory 
Manual, 2nd ed. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory. 
Snow, P. M., Zinn, K., Harrelson, A. L., McAllister, L., Schilling, J., Bastiani, M. J., 
Makk, G., and Goodman, C. S. (1988). Characterization and cloning of fasciclin I and 
fasciclin II glycoproteins in the grasshopper. Proc. Natl. Acad. Sci. USA 85, 5291-5295. 
Studier, F. W., Rosenberg, A. H., Dunn, J. J., and Dubendorff, J. W. (1990). Use of 17 
RNA polymerase to direct the expression of cloned genes. Meth. Enzymol. 185,60-89. 
Takebe, Y., Seike, M., Fujisawa, J.-I., Hoy, P., Yokota, K., Arai, K.-I., Yoshida, M., 
and Arai, N. (1988). SRa promoter: an efficient and versatile mammalian cDNA 
expression system composed of the simian virus 40 early promoter and the R-U5 segment 
of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. BioI. 8, 466-472. 
Towbin, H., Staehelin, T., and Gordon, J. (1979). Electrophoretic transfer of proteins 
from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. 
Natl. Sci. USA 76, 4350-4354. 
Zinn, K., McAllister, L., and Goodman, C. S. (1988). Sequence analysis and neuronal 
expression of fasciclin I in grasshopper and Drosophila. Cell 53, 577-587. 
77 
CHAPTER 3 
EXPRESSION OF SECRETED GRASSHOPPER F ASCICLIN I 
IN CHINESE HAMSTER OVARY CELLS AND IN 
SCHNEIDER 2 CELLS, AND FUNCTIONAL STUDIES OF 
THE EXPRESSED GRASSHOPPER FASCICLIN I 
78 
Abstract 
This chapter describes a directly secreted form of grasshopper fascic1in I produced in 
two expression systems using Chinese Hamster Ovary (CHO) cells, or Drosophila 
Schneider 2 (S2) cells. The truncated form of grasshopper fasciclin I expressed in CHO 
cells and S2 cells migrates with apparent molecular masses of 87 kDa and 72 kDa 
respectively, as compared to PI-form of CHO-derived grasshopper fascic1in I that migrates 
with an apparent molecular mass of 90 kDa. Biochemical characterization of fasciclin I 
indicates that it exists as a monomer in solution, an observation consistent with homophilic 
interaction properties only if the interaction is of low affinity. Structural studies by electron 
microscopy and circular dichroism suggest that fascic1in I has a compact structure with a 
significant content of a-helix. Fasciclin I is therefore structurally distinct from adhesion 
molecules that are members of the immunoglobulin superfamily and/or contain fibronectin 
III repeats, which are predicted to be elongated structures with flexible hinge regions 
containing predominantly l3-sheet secondary structure. 
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I. Introduction 
In an effort to eliminate the heterogeneity that may result from the portion of the PI 
tail that remains after release from the membrane with PI-PLC, we generated a directly 
secreted form by modifying the cDNA sequence of grasshopper fasciclin I to introduce a 
stop codon before the PI attachment signal. We have shown that CHO cell Jines transfected 
by an expression vector containing the truncated construct produces the truncated protein 
which is secreted into the medium. An insect expression system was also used to obtain a 
secreted form of protein containing a physiological amount of carbohydrate. The 
expression vector pRmHa3.sGfl was created and introduced into Drosophila Schneider 2 
(S2) cells. Preliminary studies show that the S2-derived grasshopper fasciclin I migrates at 
the expected molecular weight, and thus does not contain the extra -15 kDa of carbohydrate 
moieties present in the CHO-derived protein. 
With the milligram quantities of pure fasciclin I available, a biochemical 
characterization was initiated to understand the role of fasciclin I in neuronal recognition. 
Drosophila fasciclin I has been suggested to act as a homophilic adhesion molecule in tissue 
culture cells (Elkins et al., 1990a). It was therefore of interest to determine whether this 
adhesion activity would correlate with oligomerization in solution using the pure CHO- or 
S2-derived protein. However, soluble fasciclin I was found to exist as a monomer in 
solution, as analyzed by gel filtration, crosslinking experiments and electron microscopy 
that will be discussed in this chapter. An attempt to utilize S2- or CHO-expressing PI-form 
grasshopper cells to perform cell aggregation assays developed by Elkins et al. (1990a) did 
not succeed. Finally, circular dichroism analysis of the soluble protein suggests that the 
primary sequence of fasciclin I contains a significant amount of a-helical content and 
therefore its structure must differ from the ~-sheet structures predicted for adhesion 
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molecules that are members of the immunoglobulin superfamily and/or contain fibronectin 
III repeats (de Vos et al., 1992; Williams, 1988; Hynes and Lander, 1992; Jessell, 1988 ). 
II. Materials and Methods 
Reagents. DSP and NHS-biotin were from Pierce. The S2 cell line and the phsneo 
vector were gifts of Michael Jackson (Scripps Clinic). The pRmHa3 vector was the gift of 
Allen Bieber (Purdue). An S2 cell line expressing the PI-linked grasshopper fasciclin I 
under metallothionein promoter was a gift of Mark Sieger (UC Berkeley). Affi-gel 10 was 
from BioRad. Antibodies and other reagents were described in Chapter 2. All other 
chemicals were reagent grade. 
Construction of truncated forms of grasshopper fasciclin I. To obtain a 
secreted version of grasshopper fasciclin I, a stop codon followed by a BamHI site was 
inserted after residue 634 by site-directed mutagenesis (Pantelis Tsoulfas, W.-C. W., 
unpublished) (Kunkel et aI., 1987). pBJ5.GS.sGfl was generated by introducing an 
EcoRV-Not! fragment containing the modified cDNAs introduced into the filled XhoI and 
NotI sites of the poly linker of pBJ5.GS (Gastinel et al., 1992) (Fig. 1). 
For expression in insect cells, the secreted form was constructed by introducing the 
modified eDNA encoding truncated grasshopper fasciclin I as an EcoRI-BarnHI fragment 
into the EcoRI and BamHI sites of the polylinker of the pRmHa3 containing the 
metallothionein promoter to generate pRmHa3.sGfl. Molecular biological experiments 
were performed by standard methods (Sambrook et al., 1989). 
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MT 




Fig. 1. Schematic diagram showing the structures of the secreted version of two expression 
vectors, pBI5.GS.sGft and pRmHa3.sGft. 
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( Transfection ) 
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Screen by slot blot 
Fig. 2. Schematic diagram showing the strategy to clone Schneider 2 cell lines expressing 
fasciclin I. 
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Cell culture and transfection. Chinese Hamster Ovary (CHO) K I cells were 
grown in aMEM supplemented with 10% FBS, 2 mM glutamine and 100U/ml 
penicillin/streptomycin. S2 cells were grown in Schneider's medium supplemented with 
12.5% FBS, 2 mM glutamine and lOOU/ml penicillin/streptomycin. 
To generate CHO cells producing the secreted form of grasshopper fasciclin I, the 
pBJ5.GS.sGfl expression vector was introduced into CHO cells, selected and amplified 
essentially the same as described in Chapter 2. Cell supernatants of transfonnant CHO cell 
lines were filtered through a nitrocellulose paper using a Minifold II slot blot system 
(Schleicher & Schuell #SRC072/0), and immunostained wtih the MAb 3B 11 to examine 
the presence of grasshopper fasciclin I. Positive transfonnant lines were verified by 
Western blotting with a rat anti-grasshopper fasciclin I antiserum. 
For stable transfection using an insect expression system (Fig. 2), 25 j.1g of 
pRmHa3.sGfl plus 2.5 j.1g of phsneo, a selection vector, were cotransfected into S2 
Drosophila cells (lQ6 cell5/ml) cultured in lO-cm plate (10 ml of medium) according to a 
calcium phosphate procedure (Stratagene). Two days after transfection, cells were split 
into two 175-cm2 flasks and selected with 0.5-1 mg (potency)/ml ofG418 (Gibco). After 
two weeks, transformed cells were passaged for a few generations and were ready to clone 
in a soft agar (A. Bieber, unpublished). In brief, 8 ml of wild type S2 cells (105 cells/ml) 
and transformed cells (100 to 800 cells) in Schneider's medium, 12.5% FCS, 
penicillin/streptomycin, with 0.8 to 1 mg/ml (potency) of G418 were pipetted onto one side 
of a 10-cm bacteriological grade petri dish, leaving most of the surface of the plate 
uncovered. 2 ml of a 1.5% molten agar solution (48<>C; Difco #0142-02) were pipetted 
onto the opposite side of the petri plate. The contents of the plate were mixed thoroughly 
by swirling, allowed to solidify, and the plates were sealed by parafilm. Within 2 weeks 
after being cultured at 26<>C, clones became visible and were isolated under an inverted 
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microscope and grown in individual wells of a 96-well plate. Expression of protein was 
induced in plates containing cells equilibrated to 2 x 1()6 cells/ml for 2 to 3 days in serum 
free medium with 0.7 mM CUS04 and examined using Western blotting by a mouse anti-
fasciclin I antiserum or using the Minifold n slot blot system by the MAb 3B 11. 
Gel electrophoresis, and Western blot analysis. Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SOS-PAGE) was performed according to Laemmli 
(1972) and silver staining was performed according to Morrissey (1981). 
After SOS-PAGE, proteins were blotted to nitrocellulose paper according to Towbin 
et al. (1979). Protein transfer was done at 100 V for 3 hours in transfer buffer (25 mM 
Tris, 190 mM glycine, 10% methanol). The blots with transferred proteins were immersed 
in 5% non-fat dry milk in TBST solution (10 mM Tris-HCI, pH 8.0, 150 mM NaCI, 
0.05% Tween 20) for 30 minutes and then incubated with mouse anti-Drosophila fasciclin I 
MAb (608), or rat (or mouse) anti-grasshopper fasciclin I antiserum at dilution of 1: 1000 
with TBST. After 1 hour, the blots were washed three times with TBST, two times with 
TBS (10 mM Tris-HCI, pH 8.0, 150 mM NaCl), each for 10-15 minutes and incubated 
with affinity-purified horseradish-peroxidase-conjugated goat anti-mouse or rat-anti-mouse 
IgG (1 :200, diluted with TBS, Cappel) for 30 minutes. After three washes with TBS, 
twice with PBS and once with 50 mM Tris, pH 7.6, the blots were visualized using 
diaminobenzidine (DAB)-hydrogen peroxide staining solution (0.06% OAB (w/v), 0.03% 
H202 (v/v) in 50 mM Tris, pH 7.6) until the bands were suitably dark (about 5 minutes). 
Alternatively, Elite ABC kits for immunoblots from Vector Lab were used. All procedures 
were carried out at room temperature. 
Size-exclusion chromatography. Following immunoaffinity chromatography, 
fasciclin I was concentrated approximately 0.2-1 mg/ml using a vacuum dialysis apparatus 
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(Schleicher & Schuell) and a Centricon centrifugal concentrator (Amicon, 25,000 MW 
cutoff). 50 ~l of the concentrated protein were run on an FPLC Superose 12 column 
equilibrated with PBS. 
Crosslinking experiments. Purified grasshopper fasciclin I protein (-0.01-0.02 
mg/ml) was treated for 30 min at 40C with 3,3'-dithio-bis-propionic acid N-
hydroxysuccinimide ester (DSP, 100 mM as a stock in dimethylfonnamide), a thio-
cleavable homobifunctional crosslinking reagent. at concentrations ranging from 100 to 800 
Ilg/ml. Crosslinking reactions were stopped by adding glycine to 50 mM, and samples 
were analyzed by Western blotting under reducing and nonreducing conditions. 
Electron microscopy. To prepare sample for electron microscopy, grasshopper 
fasciclin I solutions at 0.1 to 0.3 mg/ml in 50 mM ammonium fonnate. pH 7.0, were 
mixed with 0.1 mg of ferritin in a 4:1 ratio. A 1O-~ portion of the mixture was sprayed on 
a 400-mesh copper grid using a bulb nebulizer. The specimens were rotarily shadowed 
with platinum at an angle of 1:5 and examined under an electron microscope (Model 420; 
Philips Electronic Instruments, Inc., Mahwah, NJ). 
Cell aggregation assays and embryo staining. S2 transfonnant lines 
expressing the PI-fonn or the secreted fonn of grasshopper fasciclin I were titered using a 
hemocytometer and cell densities were equilibrated for each experiment to 5 x 1()6 Iml in 
0.5 ml HBSS and were induced by 0.7 mM CUS04 overnight. The cells were then agitated 
at 100 rpm on a shaker platfonn for 1 hour and examined under microscope by putting on a 
microscope slide with an 18-mm square coverslip. Alternatively, transfonned S2 cells 
expressing PI-linked fasciclin I were mixed with a monolayer of confluent CHO cells 
expressing a high level of PI-linked fasciclin I, followed by agitation at 100 rpm on a 
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shaker for an hour. Cells were washed gently three times with PBS and the formation of 
rosettes was examined under microscope. 
For embryo staining, the CHO-derived fasciclin I was biotinylated essentially 
according to the manufacturer's directions (Pierce). In brief, 0.5 ml of purified fasciclin I 
(0.76 mg/ml) was reacted with 5 III of 6 mg/ml of NHS-biotin (in DMSO) for 1 hour at 
room temperature. Free NHS-biotin was removed by centrifuging with a Centricon-30 
microconcentrator (Amicon) three times. The coupling efficiency was 7 biotins per 
molecule of grasshopper fasciclin I under these conditions. Biotinylated bovine serum 
albumin (3-4 biotins per molecule) was used as a negative control. Grasshopper embryo 
staining was performed essentially the same as described by Bastiani et at. (1987) in 
collaboration with Barry Condrun For analysis of embryonic perturbation, 0.2 mg/ml of 
purified CHO-derived fasciclin I was incubated with the primary culture of grasshopper 
fasciclin I at an approximately 1: 10 dilution (Bastiani et aI., 1987). Embryos were 
observed under microscope to analyze whether there was altered pathways. 
Circular dichroism. The CD spectrum of the CHO-derived truncated 
grasshopper fasciclin I (0.21 mg/ml in 5 mM sodium phosphate, pH 7.5) was collected in 
collaboration with Dana Tamir using a Jasco J-600 spetropolarimeter. A cuvette with an 
0.1 cm pathlength was used, and the mean residue ellipticity (deg·cm2/dmol) was 
determined assuming a mean residue weight of 141. All spectra were recorded from 260 to 
185 nm and were determined as the average of five scans. The experiments were carried 
out at room temperature. 
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III. Results 
A. Expression of Secreted Forms of Fasciclin I. 
In order to remove the PI tail remaining in the PI-PLC released fasciclin I, a version 
of the cDNA encoding a secreted form of grasshopper fasciclin I was created using site 
directed mutagenesis (Kunkel et al., 1987; Pantelis Tsoulfas and W.-C. W., unpublished) 
by introducing a stop codon after amino acid 634 of grasshopper fasciclin I, which 
corresponds to the position presumably encoding the beginning of the PI linkage signal in 
the fasciclin I cDNA (Ferguson and Williams, 1988). The CHO expression vector, 
pBJ5.GS.sGn, was reconstructed, introduced into CHO cells, selected and amplified with 
the presence of the drug MSX (see Chapter 2) to obtain stable CHO transformant cells. 
The highest-expressing lines were identified by the Minifold II slot blot analysis using the 
MAb 3B 11 or by Western blotting of cell supernatants using the rat anti-fasciclin I 
antiserum. To obtain large amounts of protein, the highest-expressing CHO clones were 
grown in a Cell Pharm II hollow-fiber bioreactor device (Unisyn Fil>ertec, San Diego) in 
the presence of 100 JJ.M MSX (Table 1). The truncated grasshopper fasciclin I was isolated 
from the medium collected from the cell site of the bioreactor (-500 ml) by passing over a 
3B 11 MAb immunoaffinity column. About 0.5-1.0 mg of pure protein per daily harvest 
has been obtained. The purified secreted form of grasshopper fasciclin I migrates with an 
apparent molecular mass of -88 kDa as compared to -90 kDa for the PI-form (Fig. 3A). 
Since CHO-derived fasciclin I contains complex oligosaccharides, resulting in a large 
excess of carbohydrate (-15 kDa, see Chapter 2), an insect expression system that might 
give rise to less carbohydrate corresponding to the physiological amount of carbohydrate 
was developed. The modified cDNA encoding the secreted version of grasshopper 
fasciclin I was introduced into an expression vector, pRmHa3, containing a metallothionein 
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promoter that functions at high levels in copper-induced Drosophila Schneider cell line 
(Bunch et al., 1988), to generate pRmHa3.sGfl (Fig. 1). This plasmid was stably 
introduced into S2 cells by cotransfection with a selection vector, phsneo (Rio and Rubin, 
1985). The highest-expressing clones were identified by the Minifold II slot blot analysis 
or by Western blotting of cell supernatants, and secreted fasciclin I was purified as 
described above. About 0.5 mg of fasciclin I per liter can be obtained from supernatants of 
these cells (5 x 1()6/ml) after CUS04 induction, and this protein migrates with the expected 
molecular mass of 75 kDa on a 10% SDS-PAGE gel (Fig. 3B), indicating the small 
truncated oligosaccharide cores are added to the proteins synthesized in the Drosophila 
expression system. 
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Fig. 3. SDS-PAGE analysis of the expressed grasshopper fasciclin I. 
(A). Cell supernatants collected from the cell site of a Cell Phann II hollow-fiber bioreactor 
device were isolated by passing over a 3B 11 immunoaffinity column and eluted with acid 
conditions (pH 3.4). Fractions (lane 1 to lane 7) containing the secreted fonn of fasciclin I 
were subjected to 10% SDS-PAGE. 
(B). Western blot of three fonns of grasshopper fasciclin I, using a mouse anti-fasciclin I 
antiserum. Lane 1, the secreted form of fasciclin I from S2 cells; lane 2, CHO-derived 
truncated fasciclin I; lane 3, CHO-derived PI-linked fasciclin I. 
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B. Soluble Grasshopper Fasciclin I Acts as a Monomer in Solution 
Previous observation has shown that Drosophila fasciclin I functions as a homophilic 
adhesion molecule in tissue culture cells (Elkins et aI., 1990a). To determine whether the 
purified CHO- or S2-derived truncated grasshopper fasciclin I acts as an oligomer in 
solution correlated with this adhesion activity, we have characterized the pure material by 
gel filtration and crosslinking studies. As shown by the gel filtration profile (Fig. 4), 
concentrated fasciclin I protein from CHO or S2 transformant lines migrates in a position 
corresponding to a monomeric structure; -88 kDa for CHO-derived protein and -75 kDa 
for S2-derived protein, respectively, rather than a dimeric or higher oligomeric structure. 
In addition, crosslinking of the purified protein from CHO or S2 cells with the 
homobifunctional reagent nsp did not give rise to the appearance of a dimer or other 
oligomeric species on Western blots (Fig. 5). These data indicate that purified fasciclin I 
exists as a monomer in solution. Similar results have been observed for other homophilic 
adhesion molecules, N -CAM (Becker et aI., 1989) and cadherins (Takeichi, 1990), 
suggesting that these homophilic interaction molecules have only weak: self-affinity. 
c. Visualization of Grasshopper Fasciclin I 
In collaboration with J. P. Revel, rotary-shadowed fasciclin I preparations were 
examined by electron microscopy. Ferritin, a 24-subunit iron storage protein (Theil, 
1989), was added in the specimens as a positive control and was shown to be a dominant 
spherical structure about -200 A (Fig. 6). Fasciclin I, in contrast, appeared to be a 
rectangle-like structure with dimensions of approximately 80 A x 60 A x 40 A (after 
subtracting 10 A at each end for the shell of metal). Since the image of contrast for 
fasciclin I is weak as well as measurements of lengths are small. the accuracy of 
dimensions is about ±10 A. Nevertheless, the major fraction of these smaller rectangle-like 
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components is a monomer, which is consistent with our previous results that fasciclin I 
exists as a monomer in solution. 
Adhesion molecules such as N-CAM, ICAM-l and integrins have been suggested to 
have extended structures with potential flexible hinge regions, presumably formed by their 
tandem repeated domains (Hynes and Lander, 1992). Rotary shadowing electron 
micrographs of both N-CAM and ICAM-l showed a bent rod with an apparent hinge 
(between domains 5 and 6 in N-CAM; between domains 2 and 3 in ICAM-l) (Becker et 
al., 1989; Staunton et al., 1990 ), indicating that they are flexible molecules. Although the 
primary sequence of fasciclin I suggests it contain four tandem repeated domains, our 
electron microscopic studies suggest that they are not arranged to form a long flexible 
structure as has been hypothesized for other adhesion molecules. Another indication that 
the fasciclin I structure differs significantly from adhesion molecules that are members of 
the immunoglobulin superfamily is the finding of a significant component of a-helical 








8°<0 m N <0 oq- 10<0 C\I ~ oq-




' I , I 
, ' , 
0.005 
o 0 / .... J --- .. 5 10 15 20 25 30 
Volume (mt) 
Fig. 4. Gel filtration of purified grasshopper fasciclin I expressed from CHO cells or S2 
cells. Purified material of the secreted grasshopper fasciclin I expressed in CHO cells 
( --- ) or S2 cells (-) was run on the FPLC Superose 12 column in phosphate buffer 
saline solution at a flow rate of 0.4 mVrnin. 
93 






(B) S 800 400 100 0 800 400 100 0 
206.5 ~ 
110.9 ~ ---70.6 ~ --~.-
43.8 ~ 
28.5 ~ 
Fig. 5. Crosslinking of purified grasshopper fasciclin I expressed from CHO cells or S2 
cells. Purified material was crosslinked using a reducible homobifunctional crosslinking 
reagent, OSP, at different concentrations (100 to 800 Ilg/ml) as indicated and was subjected 
to 8% SOS-PAGE in reducing or nonreducing condition. Lane 1 to lane 4, S2-derived 
truncated grasshopper fasciclin I; lane 5 to lane 8, CHO-derived truncated grasshopper 
fasciclin I. 
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Fig. 6. Electron micrographs of rotary-shadowed soluble grasshopper fascic1in I. P 
indicates ferritin; 1, 2, and 3 indicate three different forms of fasciclin I. 
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D. Does Grasshopper Fasciclin I Mediate a Homophilic Interaction? 
To address this question, cell aggregation assays developed by Elkins et al. (l990a) 
were attempted using S2- or CHO-expressing PI-linked grasshopper fasciclin I as 
described. S2 transformant lines expressing the PI-form (derived from Mark Seeger) or 
the secreted form of grasshopper fasciclin I were titered and induced by 0.7 mM CUS04 
overnight. The cells were then agitated at 100 rpm on a shaker platform for 1 hour and 
examined if there were large aggregates. Alternatively, transformed S2 cells expressing PI-
linked fasciclin I were mixed with a monolayer of confluent CHO cells expressing a high 
level of PI-linked fasciclin I, followed by agitation at 100 rpm on a shaker for an hour, 
washed and examined if rosettes were formed. It was expected that S2 cells expressing PI-
form fasciclin I would form large aggregates, and the culture of S2-expressing PI-form 
fasciclin I with a monolayer of CHO cells expressing a high level of fasciclin I (6 x 106 
molecules per cell) would give rise to many rosettes, which then could be inhibited by 
adding purified fasciclin I or by culturing with S2 cells that produce the secreted fasciclin I. 
However, no obvious aggregation was observed in S2-expressing PI fonn of grasshopper 
fasciclin I (data not shown) and no rosettes were fonned in mixing with S2- and CHO-
expressing PI-form fasciclin I. Attempts using biotinylated fasciclin I protein to stain 
grasshopper embryos did not succeed either (B. Condron, and W.-C. W., unpublished). 
These data again suggest that homophilic interaction properties exist only in the case of a 
low affinity interaction. Therefore, a modification of oligosaccharides on CHO-derived 
fasciclin I or a different induction condition [heat shock induction in Elkins' experiments 
(1990a) whereas CUS04 induction in our experiments] might result in a loss of homophilic 
activity. Alternatively, other molecules necessary for cell adhesion might only associate 
with Drosophila fasciclin I but not with grasshopper fasciclin I in S2 cells. Finally, no 
obvious altered pathways were observed in grasshopper embryonic cultures that were 
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incubated with purified CHO-derived grasshopper fasciclin I (B. Condron, and W.-c. W., 
unpublished), indicating that fasciclin I plays a redundant role in growth cone guidance. 
E. CD Spectra 
To obtain information regarding the secondary structure of fascic1in I, a far UV CD 
spectrum of fasciclin I was analyzed in collaboration with Ilana Tamir. As shown in Fig. 
7, the CD spectrum of fasciclin I is characterized by a positive peak at 195 nm followed by 
deep negative doublets at 208 nm and 220 nm, indicating a strong a-helical character. The 
ellipticity of a protein at any given wavelength in the far UV region results from the sum of 
the contributions from the secondary structural elements with the molecule, thus allowing 
the estimation of the amounts of a-helix, ~-sheet, and ~-turn from the CD spectrum in this 
region (Greenfield and Fasman, 1969). Based on an equation developed by Greenfield and 
Fasman (1969), the a-helical content of a molecule can be calculated as 
% a-helix = [8]208nm - 4,000 
33,000 - 4,000 
where [9ho8nm is mean residue ellipticity at 208 nm. [9ho8nm can be derived using the 
equation given by 
[8] [8] measured at 208 nm x 100 208nm = ----------
C/mean residue weight x I 
where C is the concentration of protein (0.21 mglml; determined by BCA assay), mean 
residue weight is [M.W./# amino acid residues (85,000/610 = 141)], and I is the pathlength 
(0.1 cm). Since [9] is measured as 24.5 mdeg·cm2/decimole at 208 nm, the mean residue 
ellipticity at 208 nm is derived as 16,450 (Fig. 7). The amount of a-helix is thus calculated 
as 43% using the equation of Greenfield and Fasman. In addition, using Chang's 
algorithm (1978) for determining the secondary structure of a protein based on· its CD 
spectrum, it is estimated that grasshopper fasciclin I contains 37% a-helix, 0% ~-sheet, 
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19% J3-turn, and 34% irregular structure. CD is a very reliable method for detecting a-helix 
(Greenfield and Fasman, 1969), and the presence of the typical a-helical spectrum in 
fasciclin I as well as the high percentage of calculated a-helix suggests that a-helical 
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Fig. 7. Far UV CD spectra of the secreted fonn of grasshopper fasciclin I (0.21 mg/mI, in 
5 mM sodium phosphate, pH 7.0). Data is expressed as the mean residue ellipticity [0], 
calculated using a mean residue weight of 141. 
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IV. Discussion 
CHO transformant cells expressing PI form grasshopper fasciclin I synthesize the 
molecule with complex oligosaccharides that result in an extra -15 kDa carbohydrate being 
added to residual protein. In addition, the PI-PLC released protein has a PI-tail that may be 
a potential barrier to crystallization. Therefore, we have generated cell lines to produce a 
directly secreted form of fasciclin I. This was done by introducing a stop codon before the 
position presumably encoding the PI signal sequence (Ferguson and Williams, 1988) in the 
fasciclin I cDNA using site directed mutagenesis (Kunkel et al., 1987). Two secreted 
forms of expression vectors were constructed; pBJ5.GS.sGfl for generating CHO-derived 
truncated fasciclin I, and pRmHa3.sGfl for a direct production of fasciclin I from 
transformant S2 cells. We have shown that the truncated insect proteins can be efficiently 
expressed both in mammalian cell lines as well as in insect cell lines, with a apparent 
molecular weights of -88 kDa and -75 kDa, respectively. These results are consistent with 
the observations that insect cells synthesize proteins with smaller oligosaccharide cores, 
whereas mammalian cells produce proteins with complex oligosaccharides (Kuroda et al., 
1990; Carr et aI., 1989). 
Cell adhesion assays (Elkins et al., 1990a) as well as genetic analysis (Elkins et al., 
1990b) have suggested that fasciclin I may act as a homophilic adhesion molecule and 
function in one of the signal transduction pathways for growth cone guidance. To define 
the activities of fasciclin I that may be involved in axon pathfinding, several biochemical 
experiments have been done using the CHO- or S2-derived pure grasshopper fasciclin I. 
An initial characterization of this homophilic adhesion interaction in solution by gel 
filtration and crosslinking studies indicates that grasshopper fasciclin I exists as a monomer 
in solution. In addition, no homophilic interaction was observed in CHO cells or S2 cells 
expressing PI form grasshopper fasciclin I by cell aggregation assays. Attempts to stain 
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grasshopper embryos with the labeled fascic1in I did not show any staining (B. Condron, 
W.-C. Wang, unpublished). Finally, perturbation studies in grasshopper embryo cultures 
by incubation with purified grasshopper fascic1in I failed to show any obvious altered 
pathways. These results suggest that if fascic1in I possesses homophilic adhesion activity, 
it is a low affinity interaction. Similar observations have been obtained for several 
adhesion molecules including N-CAM (Becker et aI., 1989), and cadherins (Takeichi, 
1990). Clustering of adhesion molecules laterally to form an organized patch thus may be 
necessary to achieve sufficient cell-cell binding forces for triggering signaling events 
(Hynes and Lander, 1992; Takeichi, 1991). 
Electron microscopic images of fascic1in I show a compact rectangular structure with 
dimensions of approximately 80 A x 60 A x 40 A instead of an extended structure, which is 
a common topology proposed for cell adhesion molecules (Hynes and Lander, 1992; 
Becker et aI., 1989). Moreover, circular dichroism analysis suggests that the novel 
primary sequence of fasciclin I folds into a predominantly a-helical structure, whereas 
fascic1in ITI, a member of the immunoglobulin superfamily, possesses significant ~-sheet 
characteristics (I. Tamir, P. Snow, W.-C. W., unpublished). Therefore, fascic1in I may 
represent a new structural motif with significant a-helical structure distinct from the ~-sheet 
structures predicted for members of other adhesion receptors, including the 
immunoglobulin superfamily (Hynes and Lander, 1992). 
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CHAPTER 4 
STRUCTURAL STUDIES OF GRASSHOPPER FASCICLIN I 
BY X-RAY CRYSTALLOGRAPHY 
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Abstract 
This chapter discusses the preliminary structural studies of the CHO-expressed 
grasshopper fasciclin I by x-ray crystallography. Large single crystals were obtained that 
diffracted to -5 A resolution anisotropically, with diffraction in one direction to 3.5 A, 
which is insufficient for a structure determination to atomic resolution. Several strategies 
have been used to improve the quality of the crystals: (i) to produce a smaller fragment that 
may be more amenable to crystallization by proteases; (ii) to remove extra carbohydrate by 
glycosidases; (iii) to express a secreted form of fasciclin I in CHO cells to remove the 
remainder of the PI-tail; (iv) to express a secreted form in insect expression system; (v) to 
explore other crystallization conditions. The first three strategies have been tested, but 
crystals that diffract to higher resolution were not obtained. A new crystal form of CHO-
derived secreted fasciclin I using a factorial screen was derived, but it has not been 
characterized due to the lack of protein. In addition, the truncated fonn of insect-derived 
fasciclin I has the expected molecular weight (-74 kDa), and thus contains significantly less 
carbohydrate, and may be more suitable for crystallization. Future studies will focus on a 
secreted fonn of grasshopper fasciclin I using a Baculovirus expression system that allow 
to produce 10-20 mg per liter of medium (using a multiplicity of infection to insect cells of 
1 to 5). Moreover, a crystallographic investigation of Drosophila fasciclin I will be initiated 
because we are now able to purify this molecule (see Chapter 2) using a monoclonal 
antibody generated against Drosophila fasciclin I produced in CHO cells. The ultimate goal 
is to understand the structural basis of this molecule to help to elucidate its role in neuronal 
recognition at a molecular level. 
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I. Crystallization 
In principle, the crystallization of a macromolecule is detennined by solubility, an 
equilibrium thennodynamic factor, and by kinetic factors that control nucleation and 
growth. Crystals grow from nucleation centers that appear at an appropriate degree of 
supersaturation. This degree of supersaturation can be achieved by varying parameters to 
decrease the solubility of the molecule of interest, such as ionic strength, pH, temperature, 
and the presence of counter ions or organic solvents. Supersaturation is a metastable state; 
its conversion to a more stable state is kinetically controlled. The individual molecules in a 
crystal are rotationally and translationally constrained. The resulting loss of entropy is 
overcome by the fonnation of intennolecular bonds. 
The most common approach to crystallizing macromolecules is to decrease the 
solubility of a concentrated purified protein solution gradually by adding salts or organic 
solvents as precipitating agents and/or changing the pH or ionic strength of the solution 
(McPherson, 1985). At high ionic strengths, an adequate quantity of water molecules 
surrounding the protein molecules is being utilized to fonn bonds with the small ions, thus 
proteins "salt-out" of solution. Organic solvent molecules bind water to themselves as do 
the salt ions, and, in addition, they lower the dielectric constant of the solvent to reduce the 
effective electrostatic shielding between the macromolecules, and the protein is less soluble. 
Changes in pH affect protein solubility because proteins are generally least soluble when 
they have a net charge of zero (the isoelectric point). Nonetheless, the molecule may 
exhibit a number of solubility minima as a function of pH resulting from its amino acid 
composition and tertiary structure. The solubility of a protein varies as a function of 
temperature because the dielectric constant of the solvent decreases with increasing 
temperature. Since the behavior of macromolecules in solution is complex and 
unpredictable owing to their various shapes, polyvalent surface character, and dynamic 
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properties, numerous conditions must be tried to discover a particular one that yields 
crystals. 
Because of the limited amounts of protein available, the "hanging drop" method of 
Woldawer and Hodgson (1975) was used to screen for suitable crystallization conditions 
for the PI-form grasshopper fasciclin I. This method is ideally suited for screening a large 
number of conditions using small amounts of protein, and can also be used to grow large, 
single crystals for diffraction analysis. With this approach, a drop (usually 2 to 10 
microliters) of grasshopper fasciclin I (4.2 to 4.6 mg/ml) in 10 mM Hepes, 0.02% NaN3 
(pH 7.5) was prepared by mixing equal volumes of the protein and the trial precipitant 
solution on a coverslip, which was then inverted and equilibrated over a well (24-well 
plate, Linbro) containing 1 ml of the undiluted precipitant solution. In this closed system, 
the microdroplet comes into equilibrium with the reservoir by slow evaporation. 
Examination of the crystals obtained was then carried out under a stereomicroscope 
(Nikon, SMZ-2T). 
Initial attempts to crystallize PI-fonn grasshopper fasciclin I were implemented using 
precipitating agents including ammonium sulfate, ammonium citrate, ammonium 
phosphate, sodium phosphate, methylpentanediol and polyethyleneglycol (PEG) of 
molecular weights 400, 3350 and 8000. The pH was varied between 4.5 and 8.5 using 
appropriate buffers. Initially, single microcrystals were obtained from 2.0 M ammonium 
sulfate, pH 7.5, at room temperature. Since the average intensity of the x-ray diffraction 
pattern of a crystal is roughly proportional to the volume of the crystal and inversely 
proportional to the unit cell volume, it is necessary to grow crystals of a substantial size. 
Large single crystals (Fig. 1) with dimensions of 0.5 mm x 0.3 mm x 0.3 mm were 
obtained using lO-microliter hanging drops equilibrated against wells containing 1.84 M 
ammonium sulfate, pH 7.5-pH 8.5 or 1.6 M Na, K phosphate, pH 7.5-8.5 (Table 1). 
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These crystals diffract to 5 A resolution, with anisotropic diffraction to 3.5 A, using nickel-
filtered CuKa radiation from a rotating-anode x-ray generator. 
Fig. 1. Crystals of the grasshopper fasciclin I. Crystals were grown by vapor diffusion 
method and photographed with the crystallizing well. 
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Table 1. Crystallization of grasshopper fasciclin I 
4.2-4.6 mg/mt in 10 mM 1.84 M (N~hS04' pH 7.0, 
Hepes, pH 7.0, 0.02% 0.02% NaN3 
NaN3 
5.0 mg/ml in 10 mM 
Hepes, pH 7.0, 0.02% 
NaN3 
1.6 M Na, K phosphate, pH 
1.84 M ~hS04' pH 7.0, 
0.02% NaN3 
1.6 M Na, K phosphate, pH 
7.5-8.5 
12.5% PEG 8K, 0.1 M CaCI2, 
0.1 M Hepes, pH 7.5 
12.5% PEG 8K, 45 mM 
MgCI2, O.lM Tris, pH 8.5 
3 M ~hS04' 0.2 M 
Na,KTartatrate, 0.1 M Hepes, 
7.5 
IGfl represents grasshopper fasciclin I. 
crystals, dliffract to 
anisotropically, with dliffraction in two 
dlirections to only 5 A resolution; 
space group', C222] 
156A x 352A x 168A 
the same as above 
the same as above 





II. Space Group Determination 
The first single crystals of the PI-fonn grasshopper fascic1in I grown in two 
microliter hanging drops had dimensions of approximately 50 microns. X-ray photographs 
of this crystal showed diffraction to only 8 A resolution. When large single crystals (0.5 
mm x 0.3 mm x 0.3 mm) became available, screenless procession photographs taken down 
the c axis showed two mirrors in the zero and upper levels and systematic absences such 
that only reflections for which h + k = 2n were present (Fig. 2a). Screenless precession 
photographs taken down the b axis also displayed mm symmetry (Fig. 2b), indicating that 
the space group is either C222 or C222/. A 60 screened precession photograph (HOL) 
showed reflections only for which 001 = 2n. Therefore the space group is C222/. The unit 
cell dimensions are a = 156 A, b = 352 A, c = 168 A. Fig. 3. shows the relative 
orientations of the axes with respect to the external morphology of the crystal. 
To determine the number of molecules per asymmetric unit, an average crystal 
volume per unit molecular weight or V m (Matthews, 1968) was determined for a range of 
values. The asymmetric unit of the crystal is estimated to contain between two molecules, 
corresponding to a V m equal to 6.4 A3/dalton (which corresponds to a solvent content of 
81 %), and eight molecules, corresponding to a Vm equal to 1.6 (a solvent content of 23%). 
Based on a survey of 116 different protein crystals, Matthews (1968) found that the 
fraction of crystal volume occupied by solvent is usually near 43% (V m equal to 2.4) but 
may vary between 27% (1.68) and 65% (3.53). 
The low resolution diffraction limit of the grasshopper fascic1in I crystals might be the 
result of the potential structural flexibility between domains of the four-repeat structure 
(Zinn et aI., 1988), and/or chemical heterogeneity from the high degree of glycosylation of 
this molecule. Alternatively, the remaining PI tail on the C-terminus which is also 
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heterogeneous and flexible might represent another potential barrier to growth of highly 










Fig. 2. The reciprocal lattice of the grasshopper fascic1in I crystals. Two 10 screenless 
precession photographs were taken down the c axis (A) or b axis (B) at a film-to-crystal 
distance of 10 cm. The exposure time was 3 hr. Reciprocal lattice of fascic1in I crystals 
has mm symmetry, and has symmetry C2 with systematic absences such that only 
reflections for which h + k = 2n are present. A 60 screened precession photograph along 
the b axis showed a OO[ = 2n selection rule. This establishes the space group as C222j. 
The unit cell dimensions are a = 156 A, b = 352 A, c = 168 A. 
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Morphology of fl Crystals and Reflection Patterns 
Xray 
~ hkO: h + k = 2n 
Xray 
~ 
hOi: h = 2n 
X ray 
~ Okl : k = 2n 
Fig. 3. The relationship of grasshopper fascic1in I crystal morphology and cell edges. 
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III. Attempts to Improve the Quality of the Grasshopper Fasciclin I 
Crystals 
There are a number of examples in which proteolytic generation of a stable fragment 
has been used to obtain high quality crystals of a protein that crystallizes poorly in its native 
state. For example, the Fab fragments of several immunoglobulins (reviewed by Amzel 
and Poljak, 1979), the ATPase fragment of a 70 K heat-shock cognate protein (Flaherty et 
aI., 1990), and the N-terminal two domains ofCD4 (Ryu et al., 1990; Wang et al., 1990). 
As discussed in Chapter 2, however, the expressed grasshopper fasciclin I is quite 
proteolytic ally resistant and no proteases including trypsin, chymotrypsin, elastase and 
papain produced a stable fragment, suggesting that the protein is folded into a stable 
structure without obvious flexible linker sequences. This result is in accordance with our 
observation that the electron micrographs of grasshopper fasciclin I show a compact 
rectangular structure instead of an extended structure. 
In a second approach, we have used glycosidases, including neuraminidase, endo H 
and endo F to remove extra carbohydrate moieties since CHO-derived grasshopper fasciclin 
I has approximately 22 kDa of carbohydrates and is very charge heterogeneous (at least 11 
species on a native IEF gel; see Chapter 2). This type of strategy has been useful for a 
soluble form of the human CD8 which yielded diffraction quality crystals only after 
extensive treatment with neuraminidase, O-glycosidase, and V8-protease (Leahy et aI., 
1992). The glycosylated proteins (see Chapter 2) were repurified by immunoaffinity 
chromatography and put into crystallizational trials. Single crystals were obtained at the 
same conditions that yielded crystals of the untreated molecule. However, the resolution 
limit on a rotating-anode x-ray generator was not improved. These crystals were also 
examined at the Stanford Synchrotron Radiation Laboratory. Synchrotron radiation is a 
factor of several hundredfold more intense than x-rays produced by a rotating-anode 
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generator, and the resolution limits of some crystals have been extended using synchrotron 
radiation (for example see Leahy et aI., 1992). Unfortunately, the fascic1in I crystals did 
not diffract to higher resolution using synchrotron radiation. 
We next tried to express a secreted version of grasshopper fascic1in I in order to 
remove the PI tail. Two expression systems (CHO cells and Drosophila Schneider 2 cells) 
were used to produce the truncated grasshopper fascic1in I as discussed in Chapter 3. The 
apparent molecular mass of the truncated grasshopper fascic1in I from CHO cells is -2 kDa 
less than the PI-form grasshopper fasciclin I. Crystallization trials with the truncated 
protein also yield crystals at the same condition. However, these crystals still diffracted 
anisotropically using either rotating-anode or a synchrotron radiation source. We have also 
obtained a new crystal form of CHO-derived fascic1in I using a factorial screen (Carter and 
Carter, 1979) (Table 2). However, we do not have enough protein at this time to optimize 
the crystallization conditions to produce crystals large enough to characterize. 
The optimal protein for crystallization trials is the secreted form of fasciclin I 
expressed in Drosophila S2 cells. This form does not include the remainder of the PI tail 
since it is directly secreted; nor does it contain extra carbohydrate moieties (its molecular 
weight is -75 kDa, in accordance with the expected molecular weight of grasshopper 
fasciclin I expressed in vivo; see Chapter 3). However, the low yield of secreted fasciclin I 
from the highest-expressing S2 clone (0.5 mg protein/liter after a 4 day induction) makes it 
impractical to isolate the required amount of protein for crystallization trials. 
113 
IV. Future Plans 
In collaboration with Peter Snow (Suny Albany), a secreted version of grasshopper 
fasciclin I was expressed in a Baculovirus, producing 10-20 mg of protein per liter of 
medium using a multiplicity of infection of 1 to 5. With a large amount of grasshopper 
fasciclin I available, we may be able to continue pursuing other crystallization conditions. 
We will also try to crystallize Drosophila fasciclin I because we are now able to 
produce this molecule (see Chapter 2). Since the Drosophila protein is only 48% identical 
to grasshopper fasciclin I, it may have very different crystallization properties. The ultimate 
goal is to understand the structure and function of fasciclin I to help in defining its role in 
neuronal recognition at a molecular level. Thus far, there is no structural infonnation 
regarding molecules involved in cell-cell interactions in the nervous system. It is also 
interesting to note that there is a human gene homologous to fasciclin I that has recently 
been identified by a Japanese group (unpublished). Potentially, I may be able to obtain this 
cDNA (or clone it myself after the sequence is published) and then express the human 
analog of fasciclin I by using our well-established expression systems. It would then be of 
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. ApPENDIX A 
STRUCTURAL STUDIES OF A CD4 FRAGMENT 
CONTAINING Two IMMUNOGLOBULIN-LIKE DOMAINS 
118 
Abstract 
CD4, the cell-surface glycoprotein, found mainly on a subset of T lymphocytes and 
on macrophages. The primary function of CD4 is to associate with class II major 
histocompatibility (MHC) molecules on the surface of antigen-presenting cells, facilitating 
antigen recognition by the T cell receptor. The CD4/c1ass II MHC interaction is also 
essential for thymocyte differentiation. Furthermore, human CD4 is the receptor for HIV 
infection. CD4 contains four immunoglobulin-like domains in its extracellular segment. 
The HIV -binding site on CD4 lies on the first N-terminal domain, whereas the class II 
binding sites are located on the first two domains. To elucidate a structure-function 
relationship at atomic resolution, a crystallographic study of the first two immunoglobulin-
like domains of the human CD4 derived from a CD4 immunoadhesin chimeric molecule 
was initiated in collaboration with Steve Chamow at Genentech. Large single crystals were 
obtained with diffraction beyond 3 A and a complete native data set to 2.7 A was collected 
using a single crystal. However, the structure of the same CD4 fragment was solved by 
two other laboratories (Wayne Hendrickson and Steve Harrison), while we were screening 
heavy atom derivatives. Therefore we did not further pursue this project. Instead, a 
structural analysis of murine CD4 was initiated for an eventual mapping of the interaction 
between murine CD4 and a murine MHC class II protein, since our laboratory has been 
working on the structure of a murine MHC class II molecule. Section III describes the 
expression and purification of the first two domains of the murine CD4 (mVIV2) using the 
glutamine synthetase-based expression system (see Chapter 2). The CHO-derived 
m VI V2, however, acts as a covalent multimers, indicating improper folding of the m VI V2 
fragment mediated by disulfide bonds, and thus is not suitable for crystallization. Attempts 
to examine the possible mechanism resulting in misfolding are discussed. 
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I. Introduction 
T lymphocytes recognize peptide fragments of antigens bound to class I or class II 
major histocompatibility complex (MHC) molecules (reviewed in Townsend and Bodmer, 
1989). Recognition of the peptide-MHC molecules complex is mediated by the T-cell 
receptor (TcR) and either the CD4 or CD8 glycoprotein on the surface of the T cells. 
Evidence is accumulating that the hypervariable regions of the TcR contact the top surface 
of the peptide/MHC complex, whereas CD4 and CD8 bind to monomorphic determinants 
on the MHC class II and MHC class I molecules, respectively, functioning as co-receptor 
along with the a~ TcR heterodimer (reviewed in Townsend and Bodmer, 1989; Fig. 1). 
Peptides bound by MHC class I molecules are recognized by CD8+ cytotoxic T 
lymphocytes (CTLs), whereas peptides bound to MHC class II molecules are recognized 
by CD4+ (primarily helper) T cells. Recognition of a specific peptide-class I complex 
usually results in the death of the cell displaying it. Recognition of a peptide-class II 
complex induces proliferation of the CD4+ T cells and amplification of the immune 
response against the particular immunogen from which the peptide was derived. The 
engagement of CD4 and CD8 to MHC molecules may serve as a possible route for ligand-
dependent signal transduction by association with a specific tyrosine kinase (p561ck) inside 
the cells with CD4 and CD8, thus triggering an intracellular response (Veillette et al., 
1988). 
CD4 and CD8 are also critical in thymocyte differentiation and maturation, a 
process known as positive and negative selection. Biochemical and genetic studies suggest 
that interaction of non-differentiated CD4+CD8+TcR+ T lymphocytes class I MHC 
eliminates the expression of CD4, whereas interaction with class II MHC extinguishes CD8 
expression, in support of biochemical as well as genetic studies (Ramsdell and Fowlkes, 
1989; Zuniga-Pflucker et al., 1990; Robey et al., 1991; Fung-Leung et al., 1991). This 
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results in the selection of class II-reactive cells (or class I-reactive cells) that are committed 




TcR CDS TcR CD4 
MHC I MHCII 
( Antigen-Presenting Cell ) 
Fig. 1. A schematic diagram showing the interaction of CD4 or CD8 with T-cell receptor 
and MHC molecules. Petide fragments presented by MHC molecules are recognized by T 
cells through a T-cell receptor and its co-receptor, CD4 or CD8. 
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In humans, CD4 serves as the primary cellular receptor for infection by the human 
immunodeficiency virus (HIV), which is the causative agent of acquired immunodeficiency 
syndrome, AIDS (Klatzmann et aI., 1984; Dalgleish et al., 1984; reviewed by Sattentau 
and Weiss, 1988). Infection by HIV is initiated by binding of the viral envelope protein, 
gp 120, to CD4 on the T lymphocytes, followed by direct fusion of viral envelope with the 
cell membrane to introduce the viral RNA genome into the cytoplasm (reviewed by Robey 
and Axel, 1990). 
CD4 is a 55 kDa molecule, consisting of a 372-amino acid extracellular portion, a 23-
amino acid transmembrane domain, and a 38-amino acid cytoplasmic segment (Maddon et 
al., 1985, 1987; Clark et al., 1987). The extracellular portion of CD4 appears to have four 
tandem repeats with sequence similarity to immunoglobulin variable (V) regions 
(designated VI-V4) (Maddon et aI., 1985). The gpl20-binding site on CD4 lies on the 
first N-terminal domain (VI) (Peterson and Seed, 1988; Landau et aI., 1988; Arthos et al., 
1988; Clayton et al., 1989; Brodsky et aI., 1990; Ashkenazi et al., 1990), whereas the 
class II binding site may be located on VI and V2 domains (Clayton et al., 1989; Lamarre 
et al., 1989a, 1989b; Fleury et al., 1991). 
To obtain a clear picture of how the V-like domains of CD4 are folded, and define 
their mode of interaction with gp120 and MHC class II molecule, many laboratories have 
attempted to crystallize a soluble fragment of CD4 composed of the VI-V4 domains. 
Although crystals have been obtained, they diffract to -6 A only (Davis et aI., 1990; 
Kwong et aI., 1990), perhaps because of a flexible linker between V2 and V3 domains. 
Proteolytic digests suggested that the first two domains (V 1-V2) form a stable structure, 
and therefore might be more amenable to crystallization (Richardson et al., 1988; lbegbu et 
aI., 1989; Healey et aI., 1990). In collaboration with Steve Chamow at Genentech, a 
human VI V2 fragment was generated by an enzymatic cleavage of a CD4 immunoadhesin 
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(Capon et al., 1984; Chamow et aI., 1990), for a crystallographic structure analysis. 
Crystals of this fragment diffract beyond 3 A, which we will report in Section n. While 
crystallographic studies were underway in our laboratory, structure of the same fragment 
obtained by direct expression (Arthos et aI., 1989; Garlick et aI., 1990) was solved by two 
other groups to 2.3 (Ryu et aI., 1990) or 2.4 A (Wang et aI., 1990) resolution. We 
therefore did not pursue the structure determination of the human CD4 VI V2. 
As reported by Ryu et aI. (1990) and Wang et aI. (1990), the VIV2 fragment forms a 
rigid rod of about 60-65 A in length. As predicted, both domains resemble the 
immunoglobulin fold, two anti parallel ~ sheets packed against each other. An unusually 
long ~ strand forms the last strand of the VI domain and continues as the fIrst strand of the 
V2 domain, so that the two domains are arranged in tandem, one on top of the other. The 
VI domain shares signifIcant structural similarities with immunoglobulin VK domains; 
however, the counterpart of the immunoglobulin complementarity-determining region 
(CDR) 2 loop is elongated while the counterpart of the CDR3 loop is shortened. The 
folding of V2 resembles that of an immunoglobulin constant domain, but there is an 
unusual intra-sheet disulfide bond. The CDR2-equivalent loop in the VI domain, 
protruding out from the core as a prominent ridge, is thought to interact with a 
complementary groove in the gp 120. Most of the residues critical for gp 120 binding lie in 
this ridge. The "real" function of the CD4 molecule, involving the binding of the MHC 
class n antigens, was recently mapped in a surface opposite the gp 120-binding site, using a 
mutational analysis (Fleury et al., 1991). 
Because our laboratory is working on a structural analysis of a murine class II MHC 
molecule, we decided to attempt an analysis of the structure of murine CD4 to allow an 
eventual mapping of their interaction. The sequence of murine CD4 is 55% homologous to 
human CD4 (Littman and Gettner, 1987), but does not serve as a receptor for HIV. It 
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would be therefore interesting to compare two structures. Using the glutamine synthetase-
based expression system described in Chapter 2, a Chinese Hamster Ovary (CHO) cell line 
that expresses a fragment containing VI and V2 domains (mVI V2) was generated. 
However, for unknown reasons, the expressed protein forms covalent multimers and 
therefore cannot be used for crystallization, as discussed in Section III. 
II. Structural Studies of a Human CD4 Fragment, VIV2 
A. Crystallization of VI V2 
Based on the inability of other labs to crystallize V I-V 4 in a form that diffracts to high 
resolution, a project was initiated in collaboration with Steve Chamow and Dan Capon at 
Genentech towards a structural analysis of the VI V2 fragment of human CD4. This 
fragment is derived from papain cleavage of a CD4-immunoglobulin hybrid molecule (CD4 
immunoadhesin), which is a homodimer resembling an immunoglobulin without a light 
chain (Fig. 2) (Byrn et al., 1990). Each monomer of the CD4 immunoadhesin consists of 
the VI and V2 domains of human CD4 joined at its carboxyl terminus to the hinge region 
and Fc domain of IgG. Cleavage with papain releases VIV2 from the Fc fragments. Two 
forms of VI V2 that differ by approximately 1 kDa in apparent molecular mass were 
consistently observed, presumably due to two cleavage sites in the hinge region (for 
details, see Chamow et al., 1990; Appendix B). 
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VIV2 ) 
.. (Fe Domain J 
Fig. 2. Construction of the human CD4 immunoadhesin. The human CD4 immunoadhesin 
is constructed by the first two immunoglobulin-like domains (VI and V2) of CD4 
(shaded), and the Fc domain of IgG 1. 
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Initial crystallization trials to find suitable conditions yielding crystals of the VI V2 
fragment were done by the hanging drop method as described in Chapter 4 (Wlodwer and 
Hodgson, 1975). A droplet of the VIV2 fragment (7.9 mg/ml) in 50 mM MES, 0.1% 
NaN 3 (pH 6.0), was prepared by mixing equal volumes of the protein and the trial 
precipitant on a coverslip, which was then inverted and equilibrated over a well (24-well 
plate, Linbro) containing 1 ml of the undiluted precipitants. Crystallizations were attempted 
using precipitants including sodium citrate, sodium acetate, magnesium sulfate, 
polyethylene glycol (PEG) 600, 3350, 8000, methylpetanediol, ethanol, isopropanol, 
methanol, and acetone at room temperature. The growth of crystals was examined under 
stereomicroscope (Nikon, SMZ-2T). 
Microcrystals (Fig. 3A) were obtained during the first attempted crystallization of 
VI V2 with 16%-20% PEG 3350 (4K) which grew as many long and thin plates extending 
from the same origin. PEG is a polymer of various lengths that can perturb the natural 
structure of water to form a network composed partly of water. Because of this 
restructuring of water, proteins are excluded into a phase where they may crystallize. To 
verify that the thin plate-like crystals were composed of protein, crystals in three drops 
were collected in a capillary tube, washed three times, and run on a 12% SDS-PAGE gel. 
Two bands corresponding to molecular mass 19 kDa and 20 kDa were shown on the gel, 
indicating that both forms of the VI V2 fragment were crystallized. 
To improve the quality of crystals, crystallization attempts were tried in solutions 
containing PEG 4K at various pH (pH 6.5-8.5), as well as different salts (0.1 M 
ammonium sulfate, 0.2 M ammonium acetate, 0.2 M ammonium chloride, 0.2 M 
magnesium sulfate, 0.2 M lithium sulfate, 0.2 M magnesium chloride, 0.2 M calcium 
chloride, and 0.2 M sodium citrate). The best condition to produce bigger polycrystalline 
crystals was 16% -20% PEG 4K, 0.1 M ammonium sulfate, 0.1 M Tris, pH 8.5. The 
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biggest polycrystalline aggregate (-100 J.1ITI x 50 J.1ITI x 50 J.1ITI ) diffracted beyond 3 A using 
nickel-filtered CuKa radiation from a rotating-anode x-ray generator. 
Since none of the crystallization conditions gave rise to large single crystals, two 
forms of seeding were attempted: microseeding and macro seeding (McPherson, 1976). In 
the microseeding technique, polycrystalline crystals were crushed into small nucleation 
particles (1 to 10 J.lm) in the mother liquor. A dilution of the crushed seeds to the mother 
liquor is made from 1: 10 to 1: 109 and then used as a precipitating agent to set up for 
crystallization. It is only by this technique that small yet single crystals (-50 J.1ITI) grew. To 
obtain bigger crystals, the macroscopic seeding technique was used (Thaller et al., 1981). 
In this technique, a small single crystal is carefully washed to remove crystalline debris and 
denatured molecules on the crystal surface. The crystal is then transferred to a fresh protein 
solution, allowing it to grow further. This process can be repeated until the crystals have 
reached the desired size. Crystals were usually observed in 1-2 days after macroseeding. 
These crystals grew to their full size (-D.5 mm) in 1-2 weeks (Fig. 3B). 
B. Space Group Determination of VIV2 
Precession photographs of single crystals with the x-ray beam along the c axis (HKO) 
showed reciprocal lattice symmetry C2 with systematic absences such that only reflections 
for which h + k = 2n are present (Fig. 4A). A precession photograph down b (HOL), 
coinciding with the long edge of the VI V2 crystal, showed reflections for which h = 2n are 
present (Fig. 4B). This establishes the space group as C2 with unit cell dimensions a = 
134.5 A, b = 33.1 A, c = 45.6 A and f3 = 960. The asymmetric unit of the crystal is 
estimated to contain one molecule based on average volume to mass ratios (V m = 2.5) of 




Fig. 3. Crystals of the human V1V2 fragment. Crystals were grown directly (A) or with 
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Fig. 4. The reciprocal lattice of the human VI V2 crystals. Two 8° precession photographs 
of the hkO (A) and hal (B) projections of Vl-V2 crystals taken at a film-to-crystal distance 
of 10 em, operated at 50 kV, 150 rnA. The exposure time was 15 hr. Reciprocal lattice of 
V 1-V2 crystals has symmetry C2 with systematic absences such that only reflectipns for 
which h + k = 2n are present. This establishes the space group as C2. The unit cell 
dimensions are a = 134.5 A, b = 33.1 A, c = 45.6 A and ~ = 96°. 
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C. Native Data Collection and Screening of Heavy Atom Derivatives 
Crystals of VI V2 are relatively radiation resistant. A complete 2.7 A native data set 
was collected from one crystal on a Siemens electronic detector mounted on a rotating 
anode generator producing nickel-filtered CuKa radiation in 16 hours and 40 minutes (1 
minute/frame; 0 .1 deg/frame). The crystal was mounted with the unique axis along the 
spindle so that each photograph contains a reflection and its Friedel reflection. In this 
orientation, 180 degree of scanning (m) results in fourfold redundancy of the complete data 
set. The collected data set was processed with the XENGEN software package including 
autoindexing, integrating, scaling and reducing. Table 1 shows the data collection statistics 
including completeness of data and merging R values as a function of scattering angle. 
Screening for heavy atom derivatives was done by comparison of screened 
precession photographs of major zones of crystals soaked in heavy-atom compounds to 
precession photographs of native crystals. Intensity changes of some reflections with no 
alteration in the unit cell dimensions as compared with the native precession photograph 
indicate a potential isomorphous heavy atom derivative. Several heavy-atom compounds, 
including K2PtCI4, TBA4Pt2' and U02(Ach, were tried by soaking with the crystals in 
mother liquor. A potential derivative, obtained by soaking with 3 mM K2PtCl4 for 1-2 
days, was identified by an hOI precession photograph (80 ). A detector data set was 
collected. Significant changes in intensity as compared to the native data were not 
observed, perhaps because of the presence of 0.1 M (NH4hS04 in the mother liquor, 
which could produce NH3 and react with K2PtCl4 to produce K2Pt(NH3)4' At this point in 
time, we learned that this structure had been solved by two other groups (Ryu et al., 1990; 
Wang et aI, 1990) and further data collection was not pursued. Appendix B describes the 
purification and crystallization of the VI V2 fragment. 
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Table 1. Data collection statistics of the native VI V2 
4.93-3.91 966 3905 965 99.9 
3.91-3.42 963 3959 963 100.0 
3.42-3.11 946 3844 944 99.8 
3.11-2.88 948 2829 743 78.4 
2.88-2.71 934 1397 406 43.5 
00 - 2.71 5771 19804 5030 87.1 
Data collection results are shown for various successive ranges of interplanar shells. 
Values for number of predicted unique reflections, total number of measured reflections, 
number of unique reflections that exist, and fraction of theoretically possible data 
measured. 
INumber of predicted unique reflections. 
2Total number of measured reflections. 
3Number of unique reflections that exist 
4Fraction of' data observed. 
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III. Expression of a Murine CD4 Fragment in Chinese Hamster Ovary 
(CHO) Cells 
A. Expression and Purification 
A cDNA fragment encoding the flrst 184 amino acids of murine CD4 was created by 
polymerase chain reaction (PCR) (Saiki et al., 1988) using the following oligonucleotides 
as primers: 
GTCGAATTCACCACCATGTGCCGAGCCand 
GCTGGA TCCCT A TGTGCTCTGAAAAACCCCAAG. A PCR fragment was generated 
so that an EcoRI site was at the 5' end, followed by 639 bp encoding the VI and V2 
domains, and a stop codon followed by a BamHI site was introduced after amino acid 184. 
This EcoRI-BamHI fragment was then cloned into the EcoRI and BamHI sites of the 
poly linker of the expression vector pBJ5.GS (Gastinel et al., 1992) to obtain 
pBJ5.GS.mCD4. This cloning task was done by Pamela J. Bjorkman. 
To obtain CHO cells expressing the VI V2 fragment of murine CD4, we used the 
glutamine-synthetase-based ampliflable expression system as described in Chapter 2. For 
the selection of clones expressing high levels of the truncated m VI V2, medium was filtered 
through a nitrocellulose paper using a Minifold II slot blot system (Schleicher & Schuell 
#SRC072/0), and the presence of mVI V2 was veri fled by immunostaining, using the 
monoclonal antibody, GKl.5. Cells of the clone producing the highest level of mVIV2 
were grown in a Cell Pharm II hollow-fiber (Unisyn Fibertec, San Diego) bioreactor device 
in the presence of 100 J,J.M of methionine sulfoxime. 
To purify mVI V2, the monoclonal antibody GK1.5 was used for immunoafflnity 
chromatography. Ascites fluid containing GK1.5 (-10 mg/ml) was partially purifled to 
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-70% pure by 50% (NH4hS04 precipitation and dialyzed against 0.2 M NaHC03, 0.5 M 
NaCI, pH 8.6 (coupling buffer). About 50 mg of GK1.5 in 5 ml of coupling buffer were 
covalently linked to 7 ml of CNBr-activated Sepharose (-8 mg/ml) according to the 
manufacturer's directions (Pharmacia). Alternatively, Affi-Gel-lO-GK 1.5 coupled beads 
(-15 mg/ml capacity) were made in 0.1 M MES, pH 6.1, in which GK1.5 but not albumin 
(a major contaminant in the mouse ascites fluid) linked to the Affi-Gel lO beads (BioRad). 
About 500 ml of supernatants from Cell Pharm (daily harvest) were put on the column at a 
flow rate of 20 ml/hr at 40 C, and the column was washed with 500 ml of PBS, 0.05% 
sodium azide with protease inhibitors (1 mM EDTA, 100 IlM PMSF, 0.5 Ilg/mlleupeptin, 
1 Ilg/ml aprotinin). The protein was then eluted by 0.1 M sodium acetate, pH 3.2. 
Fractions of 3 ml were collected in test tubes containing 0.5 m1 of 1 M phosphate (pH 8.2) 
for immediate neutralization (Fig. 5). In general, about 0.3 mg of mVIV2 was obtained 
per daily harvest from the Cell Pharm containing a 250-ml hollow-fiber bioreactor (Table 
2). 
133 







14.4 ~ L.. 
Fig. 5. SDS-PAGE analysis of eluted fractions of purified mVl V2 expressed in CHO 
cells. Fractions (lane 1 to lane 5) containing purified mVIV2 proteins eluted from the 
GK1.5 monoclonal antibody immunoaffinity column (pH 3.2) were subjected to 12% 
SDS-PAGE and visualized by coomassie brilliant blue R-250 staining. 
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1108 cells of clone CD4.27 were inoculated into Cell Phann II on 07-30-91. 
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B. Oligomeric Multimers of the Expressed Soluble mVIV2 
Purified mVI V2 from CHO cells migrates in two forms with an apparent molecular 
mass 28 kDa and 29 kDa (Fig. 5) on a reducing 12% SOS polyacrylamide gel (SOS-
PAGE). This might be due to glycosylation heterogeneity since there is one potential N-
linked glycosylation site at amino acid 161. Similar results have been observed for the 
expressed rat VI V2 fragment from CHO cells, which is expected to have one-carbohydrate 
structure (Williams et al., 1989). When the purified m VI V2 was run on an FPLC 
Superose 12 column, however, peaks were observed at the position of the void volume, at 
a position corresponding to a monomer, and intermediate positions (Fig. 6). Fractions 
from the gel filtration chromatography were subjected to 12% SOS-PAGE in either non-
reducing or reducing condition. As shown in Fig. 6, fractions of higher molecular weights-
appeared to correspond to covalently linked oligomers, since they could be reduced to a 
monomer in the presence of ~-mercaptoethanol. To examine if these oligomers were 
produced during the low pH elution from the affinity column, fractions containing 
multimers were collected as pool I, and the monomer fractions were collected as pool II. 
Pool I was repurified by the immunoaffinity chromatography, eluted, concentrated and run 
on the FPLC Superose 12 column as described above. Fig. 7 shows a gel filtration profile 
of the repurified multimers, indicating that, first, the eluted oligomeric forms can interact 
again with the monoclonal antibody, GK1.5, and, second, that they remain as oligomers 
after repurification and re-elution. Pool II, composed of the monomer of mVI V2, 
similarly, was re-chromatographed using FPLC Superose 12 column. As expected, the 
major peak migrates in the position of a monomer. Nonetheless, proteolytic fragments, -12 
kDa and -6 kDa, appeared, indicating that either mVI V2 monomer and/or its multimers are 
unstable. These results strongly suggest that the expressed mVI V2 forms covalent 
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Fig. 6. Characterization of purified mV1V2 expressed in CHO cells. 100 ~l of purified 
mV1 V2 proteins (3 mg/ml) were applied on a FPLC Superose 12 column in 10 mM Hepes, 
0.2 M NaCl, 1 mM EDTA, 0.04% NaN3, pH 7.5, at a flow rate of 0.4 mVmin. Fractions 
(#8-#18) were subjected to 12% SDS-PAGE in either nonreducing (a) or reducing (b) 



















-'" -v lO 
':i gg:g g) ~ ID 
-v (\j~ 






















































Fig. 7. Gel-filtration profile of repurified mVIV2. Fractions of the size exclusion 
chromatography (A) were collected into two pools, pool I (higher molecular weights) and 
pool II (most are monomers ofmVIV2). Pool I was repurified, eluted, concentrated and 
was applied on anFPLC Superose 12 column (B). Pool II was concentrated and applied 
directly to the Superose 12 column (C). 
138 
Since human VI V2 has been successfully expressed in CHO cells (Arthos et al., 
1988) without problems of oligomerization, it is surprising that the analogous murine CD4 
fragment forms multimers. To check for possible point mutation(s) introduced during the 
PCR generation of the VI V2 coding sequence, mVI V2 in pBJ5.GS.mCD4 was sequenced 
completely by Ilana Tamis. The sequence corresponded exactly to the published sequence 
of murine CD4 (Littman and Gettner, 1987). Since a cysteine residue is found in the leader 
sequence, a protein with a free sulfbydryl would be generated if the signal sequence was 
not properly cleaved to generate the mature protein. To check for this possibility, purified 
mVIV2 was subjected to N-terminal sequencing (Caltech facility). The sequence obtained, 
KTLVLGKEGETAXL, exactly corresponded to the first 12 residues of murine CD4 
(Littman and Gettner, 1987), thus ruling out the possibility due to an extra cysteine in the 
uncleaved signal peptide. 
When comparing mVI V2 to the human VI V2, it is interesting to find that the human 
VIV2 is unglycosylated while mVIV2 contains a single N-linked glycosylation site. 
Surprisingly, we notice that the fourth cysteine (residue 162) isone residue C-terminal to 
the potential N-linked glycosylation site (residue 161 is Asn). Addition of N-linked 
glycosylation moieties may differ in CHO cells and murine T lymphocytes. It is possible 
that glycosylation might interfere with the formation of the disulfide bond. Both 
glycosylation of asparagine residues and the formation of disulfide bonds are 
cotranslational processes, occurring immediately after transport of the nascent polypeptide 
into the lumen of the rough endoplasmic reticulum (Rothman and Lodish, 1977; Glabe et 
al., 1980; Bergman and Kuehl, 1979). It therefore raises an interesting possibility as to 
whether such a mechanism results in misfolding for mVIV2. Future experiments will be 
attempted to examine this possibility using tunacamycin, an inhibitor for N7linked 
glycosylation. This will be important to design an efficient way to express m VI V2 for a 
structure determination, as well as important for understanding the cell biology. 
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ApPENDIX B 
ENZYMATIC CLEAVAGE OF A CD4 IMMUNOADHESIN 
GENERATES CRYSTALLIZABLE, BIOLOGICALLY 
ACTIVE Fd-LIKE FRAGMENTS 
